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resumo 
 
 
A proteína 1 associada com a lâmina (LAP1), codificada pelo gene humano 
TOR1AIP1, encontra-se localizada na membrana interna do núcleo. 
Funcionalmente a LAP1 está associada à manutenção da estrutura do envelope 
nuclear e ao posicionamento da lâmina e da cromatina. No envelope nuclear a 
LAP1 forma complexos com várias proteínas, nomeadamente lâminas tipo A e 
B, torsinas e emerina. A atividade destes complexos sugere a existência de uma 
função cooperativa entre a LAP1 e as proteínas nomeadas anteriormente, que 
será essencial, particularmente nos tecidos em que a sua expressão é 
substancial. Assim, a identificação de novos interactores da LAP1 e das suas 
respetivas vias de sinalização, será crucial para identificar e compreender as 
funções biológicas desta proteína. Ao longo deste trabalho foram utilizadas 
ferramentas bioinformáticas que possibilitaram a descoberta de novas proteínas 
associadas com a LAP1. Em primeiro lugar, o interactoma da LAP1 foi 
estabelecido através do acesso a bases de dados públicas, procedendo-se 
posteriormente à análise manual de cada uma destas interações. De seguida, a 
integração de múltiplas ferramentas bioinformáticas possibilitou a determinação 
de novas funções associadas à LAP1, designadamente a resposta a danos no 
DNA e a interação com os telómeros. Simultaneamente, os resultados 
bioinformáticos reforçaram a participação da LAP1 no processo de mitose e a 
intervenção desta proteína na manutenção da morfologia nuclear. Em particular, 
a função da LAP1 na regulação da mitose e da estrutura do envelope nuclear 
parece ter semelhanças com processo de espermatogénese. Assim, ao longo 
deste trabalho foi também estudada a distribuição da LAP1 ao longo deste 
processo de diferenciação, assim como de alguns dos seus conhecidos 
interactores, no testículo de ratinho e de humano. Em ratinho, foi possível 
determinar que a atividade da LAP1 durante a espermatogénese é mais 
significativa desde a fase VIII até ao fim da espermiogénese, sendo 
característica do desenvolvimento da manchete. Concomitantemente, alguns 
dos interactores avaliados possuem uma localização análoga à da LAP1, 
nomeadamente, as lâminas B1 e A/C, e a proteína serina/treonina fosfatase 1γ2 
(PP1γ2). Os resultados obtidos após o estudo da LAP1 ao longo do sistema 
reprodutor masculino possibilitaram a atribuição de novas e potenciais funções 
biológicas à LAP1. Assim, este trabalho poderá servir de ponto de partida para 
estudo futuros da LAP1 e da sua função na regulação de múltiplos processos 
celulares e doenças. 
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abstract 
 
The lamina-associated polypeptide 1 (LAP1) is a type II transmembrane protein 
of the inner nuclear membrane encoded by the human gene TOR1AIP1. LAP1 
is involved in maintaining the nuclear envelope structure and appears be 
involved in the positioning of lamins and chromatin. In the nuclear envelope, 
LAP1 is suggested to exist as a complex with A-type and B-type lamins, torsins 
and emerin. The presence of such complexes suggests that LAP1 may 
cooperate functionally with these proteins in tissues where they play a critical 
role. Therefore, the identification of LAP1 binding partners and the signalling 
pathways where LAP1 participates, is crucial for a better understanding of LAP1 
functions. The work described in this thesis addresses novel human LAP1 
associated proteins found through bioinformatic tools. Public databases allowed 
for the discovery of the LAP1 interactome, which was manually curated, 
identifying several functionally relevant proteins. Subsequently, the integration of 
multiple bioinformatic tools established novel functions to LAP1 such as DNA 
damage response and telomere association. In conjunction, bioinformatic results 
also reinforced the association of LAP1 with mitosis, and the already identified 
role of LAP1 in nuclear morphology. Interestingly, this association of LAP1 with 
the regulation of the nuclear envelope structure and mitosis progression, shares 
functional elements with spermatogenesis. Therefore, this work additionally 
described the localization of LAP1 and some of its interactors throughout the 
spermatogenic cycle, in mouse and human testis. The results established that 
the activity of LAP1 during the mouse spermatogenic cycle is most evident from 
stage VIII until the end of spermiogenesis, which is characteristic of manchette 
development. Concomitantly, some LAP1 interactors studied in this work share 
a similar localization, namely, PP1γ2, Lamin B1 and Lamin A/C. The results 
obtained from the study of LAP1 throughout different periods of the male 
reproductive system attributed potential new biological functions to LAP1. 
Thereby, this work can be the foundation of future studies regarding LAP1 and 
the regulation of multiple cellular processes and disease conditions. 
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1.1. THE NUCLEAR ENVELOPE 
 
In eukaryotic cells, the nuclear envelope (NE) encloses the genetic material and separates it 
functionally, constituently and temporally from the cytosol (reviewed in 1). This specialized barrier 
is comprised by the inner (INM) and outer (ONM) nuclear membranes, which are continuous with 
the endoplasmic reticulum (ER)2. The perinuclear space, that covers the lumen between the 
bilayers, spans from 30 to 50 nm in metazoans and it is also contiguous with the lumen of the 
endoplasmic reticulum (ER)3. The two concentric membranes are periodically fused at the nuclear 
pore complex (NPC), a large supramolecular structure shaping a channel between the cytoplasm 
and the nucleus2. Finally, the nucleoplasmic face of the INM comprises an underlying network of 
filaments composed of lamina proteins that confer structure and support to the nucleus4. 
Regardless of the lipid continuity between the NE and the ER, the protein content amongst the 
INM, the ONM and ER membranes is quite diverse (Figure I.1)5. Proteomics has revealed the 
complexity of the NE with the identification of multiple copies of 30 different nucleoporins (Nups) 
in the NPC, rounding up to roughly 100 proteins per NPC6. Adding to this premise, the INM was 
found to be comprised of 67 unique nuclear envelope transmembrane (NET) proteins7. Thus, the 
INM hosts a unique set of integral and associated proteins that interact directly or indirectly with 
A-type and B-type lamins, the major components of the nuclear lamina8. Alternatively, the ONM 
has been shown to be physically and constituently associated with the attachment of ribosomes 
and ER development9. In addition to allowing lateral diffusion between the NE and the ER, the ONM 
is connected to both the actin cytoskeleton network and the centrosome (Figure I.1: Mechanics and 
nucleoskeleton) 10–13. 
Protein association to these membranes is very likely time and tissue specific. Through 
emerging roles in genome organization, meiosis, mitosis, cell growth, signalling, or differentiation. 
Thereby, the NE upholds additional purposes besides separating intracellular components (Figure 
I.1, reviewed in 14).  
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Figure I.1. Biological functions of the NE and its related complexes. Genome organization in the nucleus has been 
associated to complexes that regulate replication, silencing and chromatin tethering. It has also been described that many 
proteins of the NE participate in cell signalling, development and differentiation, as well as growth control. Additionally, 
the nucleoskeleton has been described to associate to cytoskeleton in order to regulate cell positioning and 
mechanotransduction. Finally, through the interaction with the MTOC and proteins embedded in the NE have been 
implicated in the processes of meiosis and mitosis. AKT, protein kinase B; ATF2, activating transcription factor 2; BAF, 
barrier-to-autointegration factor; BAM, bag-of-marbles; CREB, cAMP response element binding; CTCF, CCCTC-binding 
factor; DNA pol., DNA polymerase; EGF, epidermal growth factor; ER, endoplasmic reticulum; ERK1/2, extracellular signal-
regulated kinases 1 and 2; FGF, fibroblast growth factor; GCL, germ cell-less; Her2, human epidermal growth factor; INM, 
inner nuclear membrane; LAD, lamina-associated domain; LAP1, lamina-associated polypeptide 1; LAP2, lamina-
associated polypeptide 2; LBR, lamin B receptor; LEM2, LEM-domain-containing protein 2; LULL1, luminal domain-like 
LAP1; MT, microtubule; MTOC, microtubule-organizing centre; mTOR, mammalian target of rapamycin; NE, nuclear 
envelope; NET37, nuclear envelope transmembrane protein 37; NET39, nuclear envelope transmembrane protein 39; 
NMC1, nuclear myosin 1c; NP, nucleophosmin; NPC, nuclear pore complex; NFAT, nuclear factor of activated T cells; ONM, 
outer nuclear membrane; P53; protein 53; PCNA, proliferating cell nuclear antigen; pro-IGF2, pro-insulin-like growth 
factor 2; Rb, retinoblastoma protein; SAMP1, spindle-associated membrane protein 1; SC, synaptonemal complex; Tel, 
telomere; TGFβ, transforming growth factor β; VRK1, vaccina-related kinase 1. Reproduced from 14.  
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1.1.1 Nuclear lamins  
 
The nuclear lamina was first described as a thin fibrous meshwork of proteins 
(approximately 15-20nm in mammals) localized in the nuclear face of the INM (Figure I.1) 15–17. This 
scaffold structure is mainly composed of A-type and B-type lamins, a family of type V intermediate 
filament (IF) proteins4. In mammals, the LMNA gene encodes A-type lamins which includes the 
major isoforms lamin A and lamin C, as well as the minor isoforms lamin C2 and lamin AΔ1018–21. B-
type lamins are comprised by the  LMNB1 gene that encodes for the major isoform lamin B1, and 
the LMNB2 gene that originates the major isoform lamin B2  and the minor isoform lamin B322–25. 
Lamins A, C, AΔ10, B1 and B2 are broadly express in somatic cells23,25,26, whereas lamins C2 and B3 
are testis specific20,24. Despite considerable research, determining lamin organization in vivo (in 
somatic cells) has been one of the major challenges in the field, as studies revealed differences 
between lamin filament assembly in vitro27 and in vivo28. 
As predecessors of IF proteins, lamins are structurally comprised  by a short N-terminal 
domain, a central rod domain with four α-helical domains (coils 1A, 1B, 2A and 2B), linker regions 
(L1, L12 and L2) that separate the N-terminal from the rod domains, and a globular C-terminal 
domain that contains: the nuclear localization sequence (NLS), an immunoglobulin (Ig) fold motif, 
and a C-terminal CaaX motif (C, cysteine; a aliphatic amino acid; X, any amino acid) (Figure I.2) 18–25. 
The CaaX motif of lamins A, B1 and B2 suffers post-translational modifications (Figure I.2) starting 
with farnesylation on the Cys residue by a farnesyltransferase (FT), followed by proteolytic cleavage 
of the aaX residues by farnesylated proteins-converting enzyme 2 (FACE2) on lamins B1 and B2 and 
by a zinc metallo-endoprotease (ZMPSTE24) in lamin A (reviewed in 29). Lastly, methylation occurs 
on the recent C terminus by a isoprenylcysteine carboxymethyltransferase (ICMT), a process that is 
known to facilitate targeting of newly synthesized lamins to the nuclear envelope membrane, 
presumably by enhancing the hydrophobic interactions in the INM (reviewed in 29). However, in the 
case of lamin A there is an additional step of C-terminal cleavage by ZMPSTE24, which in humans 
was shown to occur after Tyr646, removing 15 amino acids, including the farnesylated Cys, 
originating non-farnesylated matured lamin A  (reviewed in 29). Additional post-translational 
modifications to lamins include phosphorylation30, ADP-ribosylation31 and sumoylation32. 
Moreover, it was demonstrated that hyperphosphorylation seems to regulate lamin 
depolymerisation upon nuclear envelope disassembly on prophase, and dephosphorylation 
coincides with nuclear envelope reassembly on telophase30.  
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Figure I.2. The CaaX motif of lamins A, B1 and B2 suffers post-translational modifications. (A) Schematic representation 
of A-type and B-type lamins. (B) Post-translational modifications of A-type and B-type lamins. The process starts with 
farnesylation on the Cys residue by a FT, followed by proteolytic cleavage of the aaX residues by FACE2 on lamins B1 and 
B2 and by ZMPSTE24 in lamin A. Lastly, methylation occurs on the recent C terminus by ICMT, a process that is known to 
facilitate targeting of newly synthesized lamins to the nuclear envelope membrane, presumably by enhancing the 
hydrophobic interactions in the INM. However, in the case of lamin A there is an additional step of C-terminal cleavage 
by ZMPSTE24, which in humans was shown to occur after Tyr646, removing 15 amino acids, including the farnesylated 
Cys, originating non-farnesylated matured lamin A. NLS, nuclear localization sequence; Ig, immunoglobulin; CaaX (C, 
cysteine; a aliphatic amino acid; X, any amino acid); FT, farnesyltransferase; FACE2, farnesylated proteins-converting 
enzyme 2; ZMPSTE24, zinc metallo-endoprotease; ICMT, isoprenylcysteine carboxymethyltransferase. Reproduced from 
29. 
 
1.1.2 NE proteins and nuclear dynamics  
 
Due to localization to the periphery of the nucleus, the nuclear lamina has been associated 
with multiple functions besides giving structure and support to the nuclear envelope (Figure I.1)7.  
Lamins interact with various proteins in the INM, forming functional complexes that simultaneously 
enable the attachment of lamin filaments to the INM7. 
Metazoans have been extensively shown to express two different kinds of lamin interacting 
proteins in the INM (Figure I.1). The first group includes multiple integral INM proteins that interact 
directly with lamins, such as Nemp1 (nuclear envelope integral membrane protein 1), emerin, 
MAN1 (inner nuclear membrane protein Man1), LBR (lamin-B receptor), LAP1 (lamin associated 
polypeptide 1), NETs (nuclear envelope transmembrane proteins 8, 9, 32, 37, 39,51, 56), LEM2 (LEM 
A 
B 
7 
 
domain-containing protein 2), TMEM43 (transmembrane protein 43), LAP2β (lamin associated 
polypeptide 2β), SUN1 (Sad1-UNC homology domain-containing protein 1), SUN2 (Sad1-UNC 
homology domain-containing protein 2), Nesprins (1, 2, 2G, 3), SAMP1 (spindle-associated 
membrane protein 1), Nurim (nuclear rim protein) and UNCL (Unc-50-like) 7 (reviewed in 14,33–35). 
The second group is comprised by proteins that are not integral membrane constituents but 
interact and localize with the nuclear lamina, which include Titin, Nup53 (nucleoporin NUP53), 
SREBP-1 (sterol-response-element binding protein), c-Fos, GCL (germ cell-less protein-like 1), RB 
(retinoblastoma protein), Oct1 (octamer transcription factor 1), BAF (barrier to autointegration 
factor), HP1 (heterochromatin containing protein 1), CTCF (transcriptional repressor CTCF), E2F 
(transcription factor E2F), DP (transcription factor Dp), R-Smads (receptor-regulated SMADs), 
LAP2α, MOK2 (zinc finger protein MOK-2), LEM3, LEM4 and LEM5  (LEM domain-containing protein 
3-5) (reviewed in 14,33–35). When complexed with lamins these proteins may contribute to a vast 
array of functions, including nuclear architecture and mechanotransduction, chromatin 
organization, gene expression, epigenetic regulation, signalling pathways, replication, transcription 
regulation, mitosis and meiosis (Figure I.1, reviewed in 14).  
Most INM integral proteins are known to have morphological regulating functions (Figure 
I.1). For instance, diminished expression of LBR, affects nuclear shape and chromatin organization 
in blood granulocytes 36. However, there are exceptions, as additional enzymatic features were 
designated to this receptor, namely sterol reductase activity that might be essential to regulate 
cholesterol during human blood and bone development37. LBR also binds to B-type lamins and HP1, 
together they seem to tether and compact chromatin assisting epigenetic gene silencing 38. 
Lamina associated polypeptide (LAP), is a term coined to designate a group of INM proteins 
stably associated with the lamina in the nuclear periphery39,40. LAP1 was one of the first lamin 
binding proteins identified in the INM and comprises 3 isoforms initially described in rat: LAP1A, 
LAP1B and LAP1C40. Structurally, it is a type II membrane protein containing a nucleoplasmic N-
terminal domain, a single transmembrane segment and a C-terminal piece that protrudes into the 
perinuclear space, but in the case of LAP1C this N-terminal domain is truncated41. LAP1 remains 
poorly characterized, yet it has been known to interact with several NE constituents (described in 
section 1.1.3.2). LAP2 is a polymorphic protein that comprises at least three isotypes (α, β, γ). 
Isoforms β and γ are type II membrane proteins, consisting of a nucleoplasmic N-terminal piece, a 
single transmembrane domain and a short C-terminal segment that extends into perinuclear space. 
LAP2α lacks a transmembrane domain and is localized to the nucleoplasm42.   
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The LEM-protein family, in mammalian cells, integrates seven elements that bind directly 
to lamins: LAP2, emerin, MAN1, LEM2, LEM3, LEM4 and LEM5. This evolutionary conserved group 
is characterized by the presence of a bi-helical LEM motif which mediates binding to BAF, a 
conserved chromatin-binding protein. Functionally, lamins, LEM-domain proteins and BAF 
coordinate NE reassembly after mitosis, aiding lamina structural chromatin organization (Figure I.1) 
(reviewed in 43).  
Emerin is a single pass transmembrane protein that localizes to the INM and binds lamina 
A via its nucleoplasmic domain. Mutations in the EDM gene causes X-linked Emery-Dreifuss 
muscular dystrophy44. Functionally, emerin associates with A-type lamins, Nesprins and the SUN-
domain protein family forming the LINC (Linker of Nucleoskeleton and Cytoskeleton) complex which 
connects the nuclear envelope to cytoskeletal networks (Figure I.1) 45. In addition, a fraction of 
emerin was also detected in the ONM where it can interact directly with microtubules (MTs) and 
contribute to the positioning of the centrosome near the ONM46. 
SUN and KASH (Klarsicht/ANC-1/Syne-1 homology) domain proteins are large protein 
families localized in the INM and ONM, respectively, that bind to form LINC complexes in the 
perinuclear space12. Since SUN-domain proteins associate with lamins, and different KASH proteins 
interact either with actin, IFs or MTs, the LINC complex has multiple regulatory functions, such as 
mechanotransduction, nuclear positioning, migration, and centrosome association (Figure I.1) 
(reviewed in 45). Particular instances of cytoskeletal interactions are provided in Figure I.1, in the 
mechanics and nucleoskeleton section. The three models displayed include SUN1 and SUN2 
interacting with KASH domain proteins, such as Nesprin-1g, emerin, Nesprin-3, Nesprin-2g, and 
Nesprin-4. As Figure I.1 shows, the regulation of different mechanical features depends on the 
members of the SUN-dimer/Nesprin complexes. 
SAMP1 is a membrane-spanning protein specifically located in the INM (Figure I.1). During 
mitosis, SAMP1 is dispersed in the ER, as expected. Surprisingly, an additional fraction of SAMP1 
concentrates to the polar regions of the mitotic spindle, colocalizing with tubulin and a lipid 
membrane marker. This distinct membrane subdomain associated with the mitotic spindle, has a 
unique protein composition, namely SAMP1. This peculiar distribution of SAMP1 occurs in 
metaphase and anaphase. However, in telophase, SAMP1 is recruited back to the reforming NEs of 
the daughters’ nuclei47. 
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1.1.3 LAP1 
 
As previously noted, LAP1 has three isoforms in rodents, despite the fact that only two have 
been described in human, namely LAP1B and LAP1C. Kondo and colleagues were the first to 
successfully clone the full-length LAP1B isoform48. More recently, our group conducted the 
identification and analysis of LAP1C as the second human isoform, which is putatively N-terminal 
truncated49. In this particular study, the two human LAP1 RNAs were identified by Northern blot 
analysis, matching the existence of non-RefSeq mRNAs in GenBank with the putative LAP1C 
sequence. Therefore, these results suggest that LAP1B and LAP1C are products of different RNAs 
and thereby their generation is regulated at the transcriptional level. The LAP1 isoforms could arise 
from alternative splicing or alternative promoter usage and consequently use an alternative 
transcription initiation site. Database searches for alternative promoters, identified an upstream 
putative LAP1C translation initiation site, thereby this matter requires additional experiments. It 
will also be of interest to understand the consequences of the loss of the N-terminal domain of 
LAP1C regarding protein-protein interactions49. In addition, our group studied the resistance of the 
LAP1 isoforms (in particular LAP1C) to extraction from nuclear membranes, using triton X-100 and 
increasing salt concentrations (NaCl). It was demonstrated that LAP1C is more easily solubilized 
than LAP1B, in agreement with the observation that human LAP1C differs from LAP1B in the 5’ end 
region of the first exon located in the nucleoplasmic domain49. LAP1B and LAP1C are both localized 
in the nuclear envelope, though it has been proposed that LAP1C might also be distributed in the 
nucleus. In fact, the differential localization of the two isoforms might even signify that these two 
isoforms possible have different cellular functions49.  
The two human LAP1 isoforms seem to have diverse physiological functions. For instance, 
it was shown that different cell lines display different expressions for human LAP1C in comparison 
to LAP1B. Additionally, the analysis of human tissue determined that the expression of 
LAP1B/LAP1C is tissue specific49. Furthermore, the expression profile during neuronal 
differentiation provided a link between LAP1 expression and the state of neuronal differentiation 
of SH-SY5Y cells and maturation of rat cortical primary cultures, suggesting that LAP1 may play a 
role in those processes. It was reported that LAP1C is initially highly expressed, stabilizing later on 
the neuronal differentiation and maturation processes. Conversely, the early expression of LAP1B 
is almost undetectable but it is increasingly upregulated throughout the differentiation and 
maturation processes, when compared to LAP1C49. Recently, a study found a patient presenting a 
homozygous mutation in the TOR1AIP1 gene that causes a frameshift resulting in a premature stop 
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codon. In the presented case, expression of LAP1B was absent in the patient skeletal muscle fibres, 
but interestingly, LAP1C was overexpressed. Therefore, a possible explanation is that variation in 
the level of expression of the different LAP1 isoforms in human tissue might lead to different 
phenotypes, in the case mentioned above with the loss of function of LAP1B50.  
Protein phosphorylation is a major signalling mechanism in eukaryotic cells that is able to 
regulate the biological activity of diverse proteins51. Our group has additionally reported that LAP1B 
and LAP1C are both dephosphorylated in vitro by protein phosphatase 1 (PP1)49,52. Phosphorylation 
sites were mapped by high-performance liquid chromatography followed by mass spectrometry 
(HPLC-MS), identifying five phosphorylated residues for LAP1B and LAP1C (Ser143, Ser216, Thr221, 
Ser306 and Ser310, the numeration of the residues is relative to the human LAP1B protein 
sequence). Additionally, PP1 was confirmed to dephosphorylate two of these residues (Ser306 and 
Ser310)49. 
 
1.1.3.1 The role of LAP1 in mitosis 
 
Cell division in eukaryotes requires disassembly and reassembly of the NE in the beginning 
and at the end of mitosis, respectively. This dynamic was termed open mitosis.  Initially, MTs that 
form the mitotic spindle are exclusively cytoplasmic but later have to come into contact with 
chromosomes for correct chromosome segregation during cell division. Thereby, NE breakdown 
allows the access of the spindle MTs to chromosomes. The NE breakdown involves disassembly of 
the nuclear pore complex (NPCs), depolymerisation of lamins, spreading of most NE soluble 
components to the cytoplasm, and localization of INM proteins to the ER. The NE reassembly at the 
end of mitosis is characterized by the concentration of INM proteins and lamins to the de-
condensing chromatin, by lamin polymerization and NPCs reassembly (reviewed in53).  
Centrosomes are the main MT organizing centres and are needed to accomplish proper 
mitotic spindle organization. During the cell cycle, the centrosomes must be duplicated at S phase, 
separated at G2 phase and correctly positioned near the ONM. Accordingly, NE proteins are 
proposed to have an extremely relevant role in this process, namely emerin, which interacts directly 
with MT and anchors the centrosomes at the ONM46,53. Interestingly, LAP1 has also been implicated 
in the regulation of the NE reassembly 41,54 and the organization of the mitotic spindle 55 during 
mitosis. Besides, it seems that LAP1 is regulated by protein phosphorylation during mitosis, as 
reported for other nuclear proteins56,57, which is consistent with the fact that protein 
phosphorylation represents a crucial regulatory mechanism of cell cycle progression30,58. 
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Additionally, it has been proposed that LAP1 may be crucial in the assembly of the mitotic MT 
spindle and consequently in mitosis progression. Particularly, Neumann and colleagues55 
demonstrated that downregulation of LAP1 led to the formation of deficient mitotic spindles in 
prometaphase, since the centrosomes form weak mitotic asters and failed to generate a bipolar 
spindle leading to aberrant mitotic exit and cell death. Indeed, defects in mitotic spindle integrity 
can affect the stability of MT and therefore the levels of MT acetylation. Posteriorly, in a recent 
study performed by our group, neuronal-like SH-SY5Y cells were used as a model to study the 
intracellular levels, localization, and potential role of human LAP1 during the cell cycle59. The results 
revealed that LAP1 is differentially expressed in SH-SY5Y cells during the cell cycle (Figure I.3). For 
instance, at metaphase, anaphase and the initial stages of telophase, LAP1 was distributed through 
the cell in speckles, excluding in the chromosomal area. Interestingly, at late telophase, LAP1 was 
clearly detected encircling the chromosomes, even when they were not completely decondensed. 
The association of LAP1 with chromosomes in anaphase and late telophase may contribute to the 
reassembly of the NE, possibly by targeting lamins and membrane vesicles to the chromosomes 
surface or by anchoring chromatin to the NE59. Other INM proteins, for instance, LBR, emerin, and 
LAP2, were also found to accumulate on the surface of chromatin during anaphase/telophase in 
vivo39,60. Thus, the binding of INM proteins to chromatin accompanies NE assembly at the end of 
mitosis, while dissociation is required for NE breakdown53. 
 
Figure I.3. LAP1 localization during the cell cycle. In interphase cells LAP1 is located in the inner nuclear membrane but at 
prometaphase LAP1 is distributed through the endoplasmic reticulum. At anaphase LAP1 localizes at chromosomes 
surface and at telophase LAP1 is redistributed again to the inner nuclear membrane, but is also detected in the mid-body. 
Nuclear pore complex and nuclear lamina are also disassembled at prometaphase and NUP107-160 are the first 
nucleoporins recruited by chromatin at anaphase. Reproduced from 61. 
 
Additionally, our previous results also showed that in mitotic cells, specifically at metaphase 
and telophase, LAP1 colocalizes with acetylated α-tubulin (a marker of MTs stability) in the mitotic 
spindle and the midbody. Plus, LAP1 colocalizes with γ-tubulin in centrosomes at metaphase and 
anaphase. The localization of LAP1 in the mitotic spindle, mid-body and centrosomes strongly 
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suggests a functional association between LAP1 and these cell cycle related components. 
Moreover, LAP1 expression is reduced in mitosis-arrested cells, whereas it is upregulated in G0/G1-
arrested cells after serum deprivation. Additionally, our study concluded that LAP1 knockdown 
resulted in decreased number of mitotic cells, reduced levels of acetylated α-tubulin and lamin B1, 
anomalous centrosome positioning near the NE and decreased phosphorylation of histone H3 at 
Ser1059. Histone H3 phosphorylation has been correlated with chromosome condensation during 
mitosis62. Therefore, a decreased number of mitotic cells could be an effect of cell cycle progression 
impairment.   
All together our results indicate that LAP1 is an important protein for centrosome 
positioning near the NE59. Specifically, the altered centrosome positioning after LAP1 depletion may 
be correlated with the decrease in the number of mitotic cells observed. Interestingly, two other 
NE proteins, emerin and the novel INM protein SAMP1 are also involved in centrosome positioning 
and connection to the NE46,47. Decreased levels of tubulin acetylation could be the result of MT 
instability due to the disruption of NE integrity. As mentioned before (section 1.1.2), cytoskeleton 
elements such as tubulin are connected to the NE through the interaction with Nesprins on the 
ONM, which in turn associate with SUN-domain proteins in the INM that are lamin binding proteins, 
resulting in the formation of a LINC complex12,45. Depletion of LAP1 from the INM might cause 
disruption of protein interactions at the NE and subsequent loss of LINC complexes, which in turn 
can lead to unstable MT dynamics. 
Finally, this study also demonstrated that LAP1 is regulated by phosphorylation during both 
interphase and mitosis but seemed to be highly phosphorylated during mitosis. Therefore, it is 
proposed that LAP1 could be (de)phosphorylated in a cell cycle-dependent manner at specific 
residues, as it is the case for lamins (reviewed in8,63). Phosphorylation of lamins at different residues 
might play specific roles throughout the cell cycle. For example, phosphorylation of lamin B2 at 
Ser17 is specifically involved in lamin depolymerization and NE disassembly64. It is accepted that 
phosphorylation of lamins prompts lamin depolymerization when the NE is disassembled, whereas 
dephosphorylation leads to lamin polymerization and the end of mitosis (reviewed in8). Specifically, 
the PP1 regulatory subunit A kinase anchoring protein (AKAP)-149 recruits PP1 to the NE upon NE 
assembly in vitro and promotes lamin B dephosphorylation and polymerization65. As previously 
noted LAP1B and LAP1C are both dephosphorylated by PP152, a phosphatase that is responsible for 
the dephosphorylation of several proteins in association with cell cycle events (reviewed in 58). In 
fact, PP1 is the major mitotic lamin phosphatase responsible for dephosphorylating lamin B, 
resulting in nuclear lamina reassemby63. Additionally, PP1 mitotic associated functions include: 
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centrosome duplication, maturation and/or splitting; contribution to anaphase chromosome 
movements; spindle assembly checkpoint inactivation through dephosphorylation; removal of 
checkpoint proteins from the kinetochore by dephosphorylating dynein; outer kinetochore 
disassembly and chromosome segregation, due to dephosphorylation of Aurora B substrates; and 
targeting of endoplasmic reticulum to chromatin to induce the first step in nuclear envelope re-
assembly (reviewed in 58). 
 
1.1.3.2 LAP1 associated physiopathological functions 
 
LAP1 biological functions remain poorly understood. However throughout the years, some 
studies have proposed functions associated to proteins that bind LAP1. First and foremost, it was 
described early on that LAP1 binds directly to lamins and indirectly to chromosomes39. Therefore, 
it is reasonable to deduce that LAP1 may be involved in the positioning and organization of lamina 
and chromatin, thereby contributing to the maintenance of the NE structure39,66. Mutations in 
several genes that encode proteins of the nuclear envelope such as lamin A/C, lamin B, LBR, 
Nesprin-1, Nesprin-2 and emerin are known to cause defects of the nuclear envelope. This group 
of diseases, known as nuclear envelopathies, consist of a wide range of clinical syndromes, including 
muscular dystrophy, cardiomyopathy, lipodystrophy, mandibuloacral dysplasia, neuropathy, 
progeria, restrictive dermopathy, arthrogryposis, Pelger-Huet anomaly and leukodystrophy67,68. 
LAP1 gained more attention when it was reported to interact with torsinA in the NE69,70. A 
mutation of a single glutamic acid within torsinA is responsible for most cases of DYT dystonia, a 
neurological and movement disorder 71. Thus, LAP1 is also known as torsinA interacting protein 1 
(TOR1AIP1) and the gene encoding LAP1 is termed TOR1AIP1. More recently, LAP1 was found to 
interact with the INM protein emerin 72, which is associated with the X-linked Emery-Dreifuss 
muscular dystrophy disorder 44. Moreover, LAP1 was found to be required for the normal 
localization of emerin. Conditional deletion of LAP1 from mouse striated muscle caused muscular 
dystrophy leading to early lethality, thus arguing that LAP1 plays a crucial role in skeletal muscle 
maintenance72. Recently, the first TOR1AIP1 mutation identified is a single nucleotide deletion 
resulting in a frameshift and a putative truncated LAP1B protein (Turkish mutation). This has 
deleterious effects associated with a specific form of muscular dystrophy. A second point mutation, 
affecting both human LAP1 isoforms, was also recently described. This mutation involves the 
replacement of a single glutamic acid to alanine at position 482 (Moroccan Mutation), causing 
severe dystonia, cerebellar atrophy and cardiomyopathy (reviewed in 73).  
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In conclusion, LAP1 is suggested to exist as a complex in the nuclear envelope with A-type 
lamins, torsins and emerin. The presence of such a complex suggests that LAP1 may cooperate 
functionally with these proteins in tissues where they play a critical role. The differential expression 
of the components of this complex in different tissues may lead to changes in the complex’s 
composition and function. For example, torsinA is expressed at relatively higher levels in neuronal 
tissues whereas torsinB and torsin3 are expressed at higher levels in non-neuronal tissues74. 
Therefore, the identification of LAP1 binding partners and the signalling pathways where LAP1 
participates are crucial for a better understanding of LAP1 functions.  
 
1.2 SPERMATOGENESIS 
 
The testes of mammals are paired organs that essentially have two functions, the production 
of sperm and steroids synthesis. A single testis comprises numerous seminiferous tubules 
separated by intervening interstitial space, all enclosed by a connective tissue capsule, the tunica 
albuginea (Figure I.4) (reviewed in 75). The seminiferous tubules end in a system of narrow straight 
ducts called tubuli recti. These straight ducts are devoid of spermatogenic germ cells and empty 
into flattened spaces called the rete testis. The rete testis is located in the thickening of the tunica 
albuginea, called the mediastinum. Subsequently, the efferent ducts fuse with the head of the 
epididymis (Figure I.4). The epididymis consists of a highly coiled duct, divided into three distinctive 
regions: the head, the body, and the tail. Sequentially, sperm are initially produced in the 
seminiferous tubules and released to the tubuli recti. After passing through the rete testis, the 
efferent ducts and the head epididymis, sperm mature in the tail of the epididymis and start 
displaying forward motility76. 
 In detail, the seminiferous tubules are formed by coiled structures creating hairpin loops 
(Figure I.4) with an epithelium composed of germ cells and two different types of somatic cells, the 
peritubular cells and the Sertoli cells (reviewed in77). Essentially, seminiferous tubules are 
enveloped by a limiting membrane comprised of contractile myoid (peritubular) cells interposed 
between connective tissue layers of collagen and elastic fibers, which functionally permit 
movement of mature sperm toward the rete testis (reviewed in 75). Leydig cells, along with immune 
cells, blood and lymph vessels, nerves, fibroblasts and loose connective tissue, comprise the 
interstitial space between the seminiferous tubules. Importantly, Leydig cells produce and secrete 
the most important male sexual hormone, testosterone (reviewed in 77). 
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Figure I.4. Section of an entire human testis cut transversally. The preparation exhibits the seminiferous tubules which 
end in a system of narrow straight ducts called tubuli recti that in turn empty into flattened spaces called the rete testis. 
The rete testis is located in the thickening of the tunica albuginea, called the mediastinum. The preparation also includes 
parts of the efferent ducts that fuse with the head of the epididymis. Adapted from 77. 
 
In cross sections of testicular seminiferous tubules (Figure I.5), Sertoli and germ cells are 
intimately associated and together form an epithelium that borders a lumen. Germ cells are 
organized in a well-defined manner and form concentric layers with immature germ cells, the 
spermatogonia, residing at the base of the epithelium adjacent to the limiting membrane, and more 
advanced germ cells generally occupying successive layers (spermatocytes, early and late 
spermatids) situated closer to the tubular lumen (reviewed in 75,78).  
Sertoli cells are located within the germinal epithelium that extend to the lumen of the 
seminiferous tubules (Figure I.5) and remain mitotically inactive in adults. Sertoli cells adhere to 
germ cells to form a highly complex epithelium, in which various tight junctions form the blood-
testis barrier and regulate germ cell location and movement toward the lumen, during 
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differentiation. Additionally, these cells have the function of phagocytosis of degenerating germ 
cells and residual cytoplasmic bodies left behind by sperm. Interestingly, sperm production is 
intimately dependent on Sertoli cells since each individual Sertoli cell is in morphological and 
functional contact with a defined number of sperm. Additionally, Sertoli cells are known to 
synthesize and secrete a large variety of factors: proteins, cytokines, growth factors, opioids, 
steroids, prostaglandins, modulators of cell division etc. The Sertoli cell also mediates the actions 
of follicle-stimulation hormone (FSH) and luteinizing hormone (LH)-stimulated testosterone 
production in the testis, apparently in a stage-dependent manner. Therefore, it is generally 
assumed that Sertoli cells coordinate the spermatogenic process topographically and functionally 
(reviewed in 77,79). 
 
 
 
Figure I.5. Schematic representation of the specific functional phases in spermatogenesis (proliferation, meiosis, and 
metamorphosis) along with the respective architecture of the human seminiferous epithelium. The tubular wall is 
composed of several layers of peritubular cells (PT) and a basal lamina (BL). RB, Residual Body; LS, Late/elongating and 
elongated spermatids; ES, Early/round spermatids; P, Spermatocytes; Ad, A-dark spermatogonia (testicular stem cells); 
Ap; A-pale spermatogonia; B, B spermatogonia; SC, Sertoli cells; JC, junctional complexes constituting the blood-testis 
barrier built by interconnected Sertoli cells; 1n, haploid cells; 2n, diploid cells. Adapted from 77. 
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Accordingly, spermatogenesis takes place in the seminiferous tubules. This process is a highly 
organized and well-defined temporal event whereby undifferentiated spermatogonial germ cells 
evolve into maturing sperm over a specific time period that varies in mammals. The 
undifferentiated stem cells produce sperm throughout adult life, thereby transmitting genetic 
information to future generations, while renewing themselves to maintain a constant supply. 
Hence, spermatogenesis is characterized by three specific functional phases: proliferation, meiosis, 
and metamorphosis (Figure I.5).  In the proliferation phase, spermatogonia undergo several mitotic 
divisions to form spermatocytes which undergo two meiotic divisions to form haploid spermatids. 
The latter develop into sperm as a result of a complicated metamorphosis involving dramatic 
structural modifications to the shape of their nucleus, compaction of their nuclear chromatin, 
formation of an acrosome, and establishment of a flagellum permitting eventual motility. The series 
of modifications occurring to spermatids is referred to as spermiogenesis, a subdivision of 
spermatogenesis. Spermatogenesis thus constitutes undifferentiated spermatogonial renewal and 
proliferation, spermatogonial differentiation, meiosis of spermatocytes, and metamorphosis of 
spermatids (reviewed in 77,78,80). 
 
 
1.2.1 Mouse spermatogenesis 
 
Spermatogenesis in humans is different from the process in rodents, or other common 
mammals. Significant differences include: the 3-dimensional (3D) organization of the seminiferous 
epithelium; the number of sperm produced daily per gram of testis; and the pattern of 
spermatogonial renewal and proliferation (reviewed in 80). Additionally, in mouse, the length of the 
spermatogenic cycle is quite distinct from humans. In the mouse, the total duration of 
spermatogenesis, from the stem cell to the mature spermatid, is about 35 days (reviewed in 81). 
Moreover, in mice, an entire spermatogenic cycle takes approximately 8.6 days and is divided into 
stages I to XII, defined by particular combinations of the different stages of spermatogenic cells 
(Figure I.6). As a result, mouse spermatogenesis exhibits a wave-like progression along the tubule 
length, which is known as the spermatogenic wave. The precise timing of the cycle in adjacent 
regions of the epithelium, creates a temporal sequence of stages which is recapitulated in their 
physical layout within the tubule. This dynamic spatial pattern ensures that fully differentiated 
sperm are always available for release from a specific proportion of the epithelial surface (reviewed 
in 75). 
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Figure I.6. Cycle of spermatogenesis in the mouse. This schematic representation illustrates the stage-specific 
morphological alterations during spermatogenesis in mouse testis. There are twelve stages (designated with Roman 
numerals) in mouse spermatogenic cycle which thoroughly depicted in the scheme.  mIn, intermediate spermatogonium 
prior to mitosis; Inm, intermediate spermatogonium after to mitosis; B, B spermatogonium; Bm, B spermatogonium 
undergoes mitosis; Pl, preleptotene spermatocyte; L, leptotene spermatocyte; Z, zygotene spermatocyte; P, pachytene 
spermatocyte; D, diplotene spermatocytes; m2om, two meiotic divisions; 1–16, 16 steps in the development of 
spermatids. Adapted from 82. 
 
The spermatogenic wave (Figure I.6) is readily apparent in the mouse testis, in which 
successive stages of the epithelial cycle are arranged as a linear series of cylindrical segments along 
the seminiferous tubule. Therefore, each tubule will display a specific stage when analysed by 
immuhistochemical sectioning. In other species, for instance in human, the stages are organised in 
more complex configurations and hard to identify at first hand83. 
Currently, it is not possible to identify spermatogonial stem cells by routine microscopy, but 
spermatogonial classes can be characterized by light and transmission electron microscopy 
according to the presence and distribution of heterochromatin (Figure I.6): undifferentiated A 
spermatogonia [A single, A paired, A aligned]; differentiated A spermatogonia (A1, A2, A3, A4); 
intermediate spermatogonia; and B spermatogonia84,85. Sequentially, B-spermatogonia divide by 
mitosis forming two preleptotene spermatocytes, representing the beginning of meiotic 
prophase86. Preleptotene rest on the basement membrane, but the following leptotene, zygotene 
and pachytene spermatocytes become transit and move through the Sertoli-Sertoli barrier86. 
Preleptotene, leptotene and zygotene spermatocytes are located in specific stages and are 
identifiable by routine microscopy, although fixation artefacts might wrongfully lead to the 
observation that these cells are attached to the basement membrane. Spermatocytes are found in 
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all stages, because meiosis is a prolonged period of spermatogenesis (14 days), thus, any attempt 
to isolate specific stages of spermatogenesis for molecular analysis will include these cells. Meiotic 
cell division occurs in stage XII and comprises three phases: meiosis I, the division diplotene (2n); 
formation of secondary spermatocytes (2n), which are larger than spermatids, but rarely are found 
as the only spermatocyte in a tubular cross section; and meiosis II, division of secondary 
spermatocytes (2n) to form haploid (1n) round spermatids (reviewed in 75).  
Spermiogenesis then proceeds with the completion of four phases: Golgi, capping, 
acrosomal, and maturation (Figure I.7) (reviewed in 79). Together, these steps are extremely useful 
for the identification of specific stages in the cycle of the seminiferous epithelium. The Golgi 
apparatus is very important during the early steps of spermiogenesis as the formation of the 
acrosome highly dependent on the production of vesicles and granules containing the enzymatic 
components of the acrosomic system that will cover the developing sperm nucleus. The first three 
steps of differentiation of round spermatid formation involves a prominent Golgi apparatus. First, 
spermatids have a small, perinuclear Golgi region without an acrosomic vesicle or granule. Then, 
proacrosomal vesicles and granules within the Golgi apparatus culminate in the formation of a 
single, large acrosomal granule within a greater vesicle that will indent the nucleus. Capping in 
round spermatids, is characterized by the association of the acrosomic granule to the nuclear 
envelope and by flattening of this vesicle into a small cap over the nuclear surface. Later on, the 
acrosomic vesicle becomes very thin and the granule flattens. Finally the acrosome flattens 
completely over approximately 1/3 of the nuclear surface. In late stage VIII, shaping of the nuclei 
begins. Acrosomal steps include migration of the acrosomal system over the ventral surface of the 
elongating spermatid nucleus. Conversely, recognition of specific stages of spermatogenesis will 
typically rely on the acrosomal system observed in the round spermatids, rather than in the 
elongating cells. These spermatid steps also involve condensation of the chromatin, as the 
chromosomes are packed more tightly and stain more intensely. Maturation is observed across 
Stages III-VIII and display fewer changes in nuclear shape and acrosomal migration. The nucleus 
continues to condense and the acrosome matures into a thin structure that protrudes at the apex 
but covers nearly all the nucleus, except for the portion connected to the tail. Excess cytoplasm 
leads to the development of residual bodies in stage VIII, resulting in the formation of prominent 
cytoplasmic lobes, which contain unused mitochondria, ribosomes, lipids, vesicles and other 
cytoplasmic components. The residual bodies are excised between steps 14-16 of elongated 
spermatids noticeable in Figure I.6 (reviewed in 75,79,87).  
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Figure I.7. Process of spermiogenesis involving dramatic structural modifications. Spermiogenesis proceeds with the 
completion of four phases: Golgi, capping, acrosomal, and maturation. The Golgi apparatus surrounds the condensed 
nucleus, becoming the acrosomal cap. One of the centrioles of the cell elongates to become the tail of the sperm. A 
temporary structure called the manchette assists in this elongation. Spermatids orient the tails towards the lumen, away 
from the epithelium. The excess cytoplasm, known as residual bodies, is excised and later phagocytosed by surrounding 
Sertoli cells in the testes. Adapted from 88. 
 
1.2.2 Human spermatogenesis 
 
In humans, germ cells have the following terminology: A-dark spermatogonia; A-pale 
spermatogonia; B-spermatogonia; preleptotene, leptotene, zygotene, pachytene, and diplotene 
spermatocytes; secondary spermatocytes; spermatids; and spermatoza (Figure I.8). 
Spermatogonial proliferation and differentiation involve only A pale-spermatogonia, since A dark 
spermatogonia do not show proliferating activity under normal circumstances and are believed to 
divide only rarely. Indeed, A pale-spermatogonia divide and differentiate into two B spermatogonia, 
which in turn, divide to form preleptotene spermatocytes. Meiosis of spermatocytes includes the 
last synthesis of DNA in preleptotene spermatocytes and 2 meiotic divisions to form spermatids 
(Figure I.8). Then, spermiogenesis results in the transformation of a round spermatid to an 
elongated mature spermatid as described previously in Figure I.7. Finally, spermiation occurs when 
the structures and connections anchoring a mature spermatid to a Sertoli cell disrupt, so that sperm 
cells are released into the tubule lumen. In humans, the interval between commitment of an A pale-
spermatogonium to proliferate and spermiation of resulting sperm averages 74 days (reviewed 
in77,80). 
Initially, multiple spermatogonia are connected by intercellular bridges, which provide 
cytoplasmic continuity among members of a cohort of cells, except when cell death eliminates a 
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connecting cell. These cohorts of germ cells are layered, with the youngest near the basement 
membrane. Later on, Sertoli cells systematically move maturing spermatids towards the tubule 
lumen (Figure I.5). Collectively, the 4–5 cohorts of germ cells theoretically developing concurrently 
at a circumscribed location in a tubule are termed as stages. Six stages were normally used to 
describe and study spermatogenesis in humans (designated with Roman numerals) with two to four 
cellular stages usually evident in a cross-section of a human seminiferous tubule. However, a new 
stage classification was proposed on the basis of acrosomal development made visible by 
immunohistochemistry (IHC), distinguishing twelve stages89. Overall, the interval between the 
initial differentiation of A-pale spermatogonia and the spermiation of resulting sperm averages 74 
days  (reviewed in 80). 
Stage identification can be defined in several ways, but inevitably, this requires recognition 
of specific cell types (Figure I.8). Nevertheless, the appearance of germ cells is highly dependent on 
methods of fixation, embedment, staining, and visualization, being extremely difficult to determine 
by IHC procedures, particularly in cross sections of the human tissue  (reviewed in 79,80). 
 
 
Figure I.8. Cycle of spermatogenesis in human. This schematic representation illustrates the stage-specific morphological 
alterations during spermatogenesis in human seminiferous tubules. There are twelve stages (designated with Roman 
numerals) in the human spermatogenic cycle, which are thoroughly depicted in the scheme. Ad, A-dark spermatogonia; 
Ap; A-pale spermatogonia; B, B spermatogonia;  pL, preleptotene spermatocyte; L, leptotene spermatocyte; Z, zygotene 
spermatocyte; eP, early pachytene spermatocyte; mP, mid-pachytene spermatocyte; lP, late pachytene spermatocyte; D, 
diplotene spermatocyte; SS, secondary spermatocytes;  1–12, first 12 steps in the development of spermatids.  Adapted 
from 82.   
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1.2.3 NE shaping during spermatogenesis  
 
The nuclear envelope undergoes evident changes in the course of spermiogenesis (Figure 
I.7). Throughout the nuclear shaping and condensation process, excess nuclear membrane is 
eliminated into the posterior cytoplasm in the form of two continuous sheets at either side of the 
implantation fossa (region where the centrioles connect to the NE). The remaining membrane 
forms two short extensions at the caudal margin of the nucleus resulting in a redundant nuclear 
envelope in sperm. In order to reduce the volume of the nucleus and the nuclear envelope, 
elimination of nuclear excess is concomitant with chromatin condensation. These series of 
modifications are accompanied by concentration of stacked lamellae along the posterior margin of 
the NE, nuclear blebbling, and concentration of nuclear pores to the post-acrosomal region. All 
these morphologic changes seem to be associated with the loss of nuclear contents during the 
gradual reduction in nuclear volume (reviewed in 81,90). 
A curious “organelle” worth mentioning when referring to the NE dynamics in 
spermatogenesis is the chromatoid body. This granular component localizes to cytoplasm and is 
mainly responsible for regulating RNA processing through the differentiation process. The 
chromatoid body moves in relation to the NE in two different ways: either along the NE on a wide 
area surrounding the Golgi apparatus, developing frequent transient associations with this 
organelle; or perpendicular to the nuclear envelope. Additionally, it has been observed to be 
located very transiently at the top of prominent outpocketing of the nuclear envelope with 
apparent material continuities through nuclear pore complexes with intranuclear particles 
(reviewed in 81,90). 
 
1.2.4 NE proteins throughout spermatogenesis 
 
The role of nuclear envelope components has been investigated in relation to the various 
phases of spermatogenesis. Importantly, lamins, LAP2, LBR, and elements of the LINC complex are 
amongst nuclear envelope proteins with more prominent associations to multiple functions in the 
spermatogenic cycle91–97.  
As part of a differentiation process, spermatogenic cells suffer major structural and 
morphological alterations throughout the cycle.  When compared with somatic cells, the nuclear 
envelope of mammalian spermatogenic cells shows a series of peculiarities. For instance, among 
somatic lamins, lamin A, C, and B1 are expressed during spermatogenesis. Lamin B2 is not present 
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in any phase of this differentiation process98,99. Instead, two short gametogenesis-specific lamins 
appear at different stages to become part of a reformed lamina. These are the A-type lamin C2 that 
is selectively expressed during meiotic prophase I100, and lamin B3, a short lamin B2 isoform whose 
expression is restricted to postmeiotic stages101. Compared to their somatic counterparts, both 
gametogenesis-specific lamins are N-terminally truncated versions, lacking the complete N-
terminal head including a significant part of the rod domain. These domains are replaced by short 
unique sequences 102. Interestingly, from the investigations on somatic lamins it is known that the 
domains that are absent in lamins C2 and B3 seem to be involved in the dimerization as well as the 
formation of more complex structures. According to this, it has been proposed that lamins C2 and 
B3 would supply a flexible setting to the NE100. 
Interactions between the chromosomes and the nuclear envelope might be important for 
meiotic pairing. Particularly, in early meiotic prophase, chromosomes become attached to the 
nuclear envelope via their telomeres. This attachment is highly dynamic as it allows telomeres to 
move within the nuclear envelope and to congregate at one of its poles in order to form a so-called 
bouquet and to move apart later during pachytene spermatocytes. Telomere movements at the 
plane of the nuclear envelope are suggested to allow chromosome recognition as well as the stable 
pairing of the homologues (reviewed in 102). Lamin C2, in particular, presents a series of peculiarities 
that are consistent to the notion that it fulfils specific functions, different from that of other A-type 
isoforms. This isoform is selectively expressed during the first meiotic prophase. Later in meiosis, it 
is no longer detectable by IHC and biochemical methods100. Remarkably, lamin C2 is highly enriched 
at the attachment sites of the telomeres. In light of this specific localization pattern and on basis of 
the proposed influence of the N-terminal truncation on the polymerization properties of lamin C2, 
this isoform might lead to a local flexibility of the nuclear envelope at the attachment sites that in 
turn enables the movement of telomeres and therefore supports pairing, recombination, and 
synapsis92. Additionally, it is proposed that the C2-containing domains might also function as local 
reinforcements of the NE that would give to the subjacent membrane a higher mechanical stability 
that would be required for the proper attachment to the  synaptonemal complex (Figure I.1)92. 
Furthermore, examination of the testes of Lmna-/- mice revealed that spermatogenesis is 
dramatically affected, as almost no post-meiotic stages appeared within the seminiferous 
tubules103. Correspondingly, virtually no sperm was found in the epididymis. Recently, investigation 
of C2-/- mice that show normal expression of all other A-type lamins, recapitulates the meiotic 
failure seen in Lmna-/- mice, where spermatogenesis was disrupted and defects in meiosis-specific 
processes were observed. In addition, it was observed that chromosomes frequently fail to synapse 
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and they engage in heterologous associations or show aberrant telomere-telomere interactions, 
representing defects that are rare in wild-type spermatocytes. Lastly, as a result of extensive 
apoptosis and failure of sperm maturation, males are completely infertile104. Conversely, lamin A/C 
was shown to be expressed in the mouse testis not only in the different stages of spermatogenesis 
but also in mature sperm99. 
Alternatively, the nuclear lamina of spermatids is mainly composed of lamin B1 and the 
spermiogenesis-specific lamin B3. In contrast to meiotic stages, no A-type lamins are detectable at 
any time101. An additional major difference deals with lamin distribution. In round spermatids, lamin 
B3 was detected at the nuclear periphery as well as diffusely distributed in the nucleoplasm. Later, 
lamin B3 of the nuclear envelope and the nucleoplasm progressively polarize at the posterior pole 
of elongating spermatid nuclei where they accumulate before becoming undetectable at the end 
of spermiogenesis101. As mentioned above regarding lamin C2, Lamin B3 has peculiar 
polymerization properties that would possibly provide the nuclear periphery of spermatids with a 
flexible condition, which in turn would be required for nuclear reshaping. Lamin B3 becomes 
polarized as spermiogenesis progresses. Interestingly, a similar polarization could be observed for 
lamin B1 and the inner nuclear membrane proteins LAP2 and LBR 91,96,101. Currently, the molecular 
basis and functional significance of this redistribution is unclear. However, due to chromatin-
binding associated functions of most of the nuclear envelope proteins involved, it can be speculated 
that nuclear envelope remodelling would contribute to the process of sperm-specific chromatin 
reorganization 91,96.  
Adding to the interest of lamin function in this differentiation process, the role of two lamin 
interacting proteins (LAP2 and LBR) was ascertained during spermatogenesis. Interestingly, LAP2 
and lamin B1 seem to be involved with changes in chromatin organization that occur during 
spermiogenesis. During spermiogenesis the nuclear envelope undergoes a profound reorganization 
that leads to the formation of a domain in the posterior pole, which differs in morphology from 
other regions of the spermatid nuclear periphery. LAP2 and lamin B1 both progressively localize to 
the posterior pole (centrioles) of elongating rat spermatid nuclei. By moving to the posterior pole, 
the chromatin binding sites at the nuclear envelope would possibly contribute to the achievement 
of the non-random, sperm specific chromatin distribution. Also, as mentioned earlier (chapter 
1.1.1), nuclear envelope proteins, in particular the lamins, play an important role in chromatin 
dynamics and function. According to this evidence, it was purposed that the progressive 
disappearance of lamin B1 and LAP2 observed in elongating spermatids may signify the process of 
chromatin condensation and inactivation that normally takes place during spermiogenesis91. 
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Similarly, in elongating spermatids, another lamin-binding protein, LBR, temporarily associates with 
P1 protamine. During mammalian spermiogenesis, histones are replaced by protamines P1 and P2. 
As a result of this exchange, the chromatin is compacted into a volume of about 5% of that of a 
somatic cell nucleus, through a phosphorylation regulated process96. 
Equally relevant for the associative study of nuclear envelope proteins throughout 
spermatogenesis are LINC complexes. As previously mentioned (section 1.1.2), LINC complexes are 
nuclear envelope bridging protein structures formed by interaction of SUN and KASH proteins. They 
physically connect the nucleus with the peripheral cytoskeleton and are critically involved in a 
variety of dynamic processes, not only nuclear anchorage, movement, positioning and shaping, as 
well as meiotic chromosome dynamics95,97. 
One example is the attachment of meiotic telomeres to the NE which is mediated by SUN-
KASH protein complexes (Figure I.1)105. For instance, SUN1 is essential for the efficient attachment 
of telomeres to the NE, and SUN2 also appears to be involved in the tethering of meiotic telomeres 
to the NE. In the absence of SUN1, an unexpectedly large proportion of telomeres are still able to 
attach to the NE and, beyond this, are also able to move within the NE, forming bouquet-like 
clustered telomere patterns. This suggests that in the SUN1 deficient background some of the 
telomeres not only succeed to establish a tight connection to the NE, but even become linked to 
the cytoskeletal motor system. Consistent with this observation, is that in Sun1-/- mice the NE-
attached telomeres colocalize with SUN2 and KASH5, suggesting that telomere attachment is 
mediated by SUN2/ KASH5-LINC complexes in SUN1 deficient meiocytes95. 
During mouse sperm development, particularly spermiogenesis, two novel distinctive LINC 
complexes were discovered, namely, SUN3-Nesprin1 and SUN1g-Nesprin3. These two LINC 
complexes specifically polarize to opposite spermatid poles of the nucleus, connecting sperm-
specific cytoskeletal structures. So, formation of the mammalian sperm head seems to involve 
assembly and different polarization of these two novel spermiogenesis-specific LINC complexes. 
Therefore, these LINC complexes connect the differentiating spermatid nucleus to surrounding 
cytoskeletal structures to enable its directed shaping and elongation, which in turn is a critical 
parameter for male fertility97. 
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When compared to proteins discovered contemporaneously, strikingly, the biological 
functions of LAP1 remain unknown. Therefore, the study of this INM protein interactors’ using 
bioinformatic tools might shed some light into its associated cellular pathways and functions. 
 In the past, mutations in LAP1 and its interactors have been vastly associated to several 
envelopathies. Given the major role of the NE in the differentiation process, LAP1 most prominent 
interacting proteins have been systematically studied through the course of spermatogenesis. 
However, LAP1 expression or localization have never been investigated during this differentiation 
process nor it has been analysed in sperm. Therefore, it was our objective to reveal the main 
function of LAP1 throughout spermatogenesis and its possible association to infertility. 
 
 Thus, the specific aims of this dissertation are the following: 
 
 To determine LAP1 interactors using bioinformatics tools; 
 To establish the main cellular pathways and functions associated with LAP1, based on the 
bioinformatic study of its interactors; 
 To determine the localization of LAP1 and some of its interactors in the testis;  
 To evaluate if LAP1 and its interactors might potentially be relevant to the differentiation 
process in spermatogenesis. 
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LAP1 is suggested to exist as a complex in the nuclear envelope with A-type and B-type lamins, 
torsins and emerin39,66,67,69,70. The presence of such complexes suggests that LAP1 may cooperate 
functionally with these proteins in tissues where they play a critical role74. Therefore, the 
identification of LAP1 binding partners and the signalling pathways where LAP1 participates are 
crucial for a better understanding of LAP1 functions. Therefore, the work described in the chapter 
II addresses the novel human LAP1 associated proteins found through bioinformatic tools. This 
work was included in the manuscript entitled: “Lamina Associated polypeptide 1 (LAP1) 
interactome and its functional features”, published in the journal Membranes. 
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“Lamina Associated polypeptide 1 (LAP1) Interactome and its Functional Features” 
 
Joana B. Serrano, Odete A. B. da Cruz e Silva, and Sandra Rebelo 
Laboratório de Neurociências e Sinalização, iBiMED, DCM, Universidade de Aveiro, Campus 
Universitário de Santiago, Agra do Crasto, 3810-193 Aveiro, Portugal 
 
 
Abstract 
Lamina-associated polypeptide 1 (LAP1) is a type II transmembrane protein of the inner 
nuclear membrane encoded by the human gene TOR1AIP1. LAP1 is involved in maintaining the 
nuclear envelope structure and appears be involved in the positioning of lamins and chromatin. To 
date, the precise LAP1 function is not fully elucidated but analysis of its interacting proteins will 
permit unravelling putative associations to specific cellular pathways and cellular functions. Public 
databases allowed the identification of the LAP1 interactome, which was curated. In total, 41 
interactions were identified. Several functionally relevant proteins, such as TRF2, TERF2IP, RIF1, 
ATM, MAD2L1 and MAD2L1BP were identified and might support putative functions proposed for 
LAP1. Furthermore, by making use of the Ingenuity Pathways Analysis tool and submitting the LAP1 
interactors, the top two canonical pathways include “Telomerase signalling” and “Telomere 
Extension by Telomerase” and top functions include “Cell Morphology”, “Cellular Assembly and 
Organization” and “DNA Replication, Recombination, and Repair”. Once again, putative LAP1 
functions are reinforced but novel functions are emerging. 
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2.1 INTRODUCTION 
 
The eukaryotic nucleus is a complex organelle enclosed by a highly organized double 
membrane, the nuclear envelope (NE). The NE separates the nucleus from the cytoplasm and is 
essentially composed by inner nuclear membrane (INM), the outer nuclear membrane (ONM), the 
nuclear pore complexes (NPCs) and nuclear lamina. The INM and ONM are separated by the 
perinuclear space of 40-50nm of diameter and are crossed and therefore connected at the NPCs. 
The perinuclear space is continuous with the lumen of the endoplasmic reticulum (ER) and the ONM 
is continuous with the rough endoplasmic reticulum membrane that comprises the ribosomes. The 
nuclear lamina is composed by lamins which are type V intermediate filament proteins exclusively 
found in the nucleus and are associated with INM proteins. The NE and NE proteins have received 
more attention in the last few years and there is increasing evidence that the NE is responsible for 
integration of many cellular functions, including chromatin organization, signalling pathways, 
transcription regulation and cytoskeletal organization106–108. 
The nuclear membranes are considered an interconnected membrane system associated 
with the ER that comprises a specific group of proteins that are specifically enriched in the INM and 
ONM, but not in the ER. Of these, approximately 80 transmembrane proteins are concentrated in 
the INM7 and a significantly lower number is concentrated in the ONM. Regarding the INM proteins 
some remain uncharacterized, but other were found to interact with lamins and/or chromatin. One 
of the first lamina associated proteins identified was lamina-associated polypeptide 1 (LAP1)40 
which is a type II transmembrane protein of the inner nuclear membrane encoded by the human 
gene TOR1AIP1. In rats, three LAP1 isoforms were described and are derived by alternative RNA 
splicing, being designated as LAP1A, LAP1B and LAP1C with molecular weights of 75, 68 and 55 KDa, 
respectively40,41. In humans, the LAP1B isoform was previously identified by Kondo et al.48 and we 
recently identify a novel human isoform, the LAP1C. This new isoform is N-terminally truncated, 
with a molecular weight of approximately 55 KDa contrasting with the 68 KDa of the LAP1B49. The 
function of LAP1 remains poorly understood. However, several LAP1 binding partners have been 
identified as is the case of lamins (directly binding) and chromosomes (indirectly binding)39. 
Therefore it is believed that LAP1 might be involved in the positioning of lamins and chromatin in 
close proximity with the NE, thereby contributing to the maintenance of NE structure41,109. Another 
important LAP1 binding protein identified was torsinA, which is the central protein in DYT1 
dystonia69. A mutation of a single glutamic acid within torsinA (∆E-torsinA) is responsible for DYT1 
dystonia, a dominantly inherited neurological and movement disorder characterized by prolonged 
involuntary twisting movements71. Interestingly, while the wild type torsinA is localized in both ER 
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and the  perinuclear space, the mutated torsinA (∆E-torsinA; pathogenic variant) preferentially 
concentrates in the perinuclear space110,111. Of note, torsinA variants with decreased ATPase activity 
bind more efficiently to LAP1. More recently, LAP1 was found to interact with another INM protein 
named emerin70 that is associated with the X-linked Emery-Dreifuss muscular dystrophy44. The 
interaction of these two INM proteins is mediated by their nucleoplasmic domain, particularly 
emerin binds to LAP1 residues 1-33070. We recently reported that the human LAP1B binds to 
protein phosphatase 1 (PP1) in the nucleoplasm domain and that it is dephosphorylated by this 
phosphatase52. Furthermore, by mass spectrometry we identified 5 different LAP1 phosphorylated 
residues: Ser143, Ser216, Thr221, Ser306 and Ser310. From these, it was possible to establish that 
only Ser306 and Ser310 are dephosphorylated by PP149.  
Recently, two mutations were identified of TOR1AIP1 gene were directly associated with 
disease conditions. The first TOR1AIP1 mutation (‘Turkish’ mutation) was reported and it affects 
three members of a Turkish family with an autosomal recessive limb-girdle muscular dystrophy with 
joint contractures. It was predicted that this c.186delG mutation, truncates the 584 amino acid 
LAP1B protein to an apparently non-functional protein, only 83 amino acids long112. Consequently, 
expression of LAP1B was absent in the skeletal muscle fibres of these patients. The authors also 
showed, by ultrastructural examination of the muscle fibres, that patients had intact sarcomeric 
organization but clearly evident alterations of the nuclear envelope including nuclear 
fragmentation. Of note, this study places LAP1B as a pivotal protein associated with striatal muscle 
function and increases the number of genes associated with nuclear envelopathies. A second 
TOR1AIP1 mutation (‘Maroccan’ mutation) was reported in a boy, born from consanguineous 
healthy parents, who developed rapidly progressing dystonia, progressive cerebellar atrophy, and 
dilated cardiomyopathy. Upon whole exome sequencing a homozygous missense mutation in 
TOR1AIP1 was identified, resulting in a highly conserved glutamic acid change to alanine at amino 
acid 482113. The in vivo studies performed by the authors indicated that the patients revealed 
reduced expression levels of LAP1 and its misallocation and aggregation in the endoplasmic 
reticulum113. Of note, both LAP1 human isoforms (LAP1B and C) are affected by this mutation. These 
two mutations strengthen functional association of LAP1 with DYT1 dystonia (in neurons) and 
muscular dystrophy (skeletal muscle)73. 
To date the precise function of LAP1 is not fully elucidated. However a significant amount 
of work has been associated with the identification and functional characterization of LAP1 
interactions, particularly with lamins, torsinA, emerin and PP1. The identification of additional LAP1 
binding proteins and their association to specific cellular pathways and cellular functions are 
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therefore crucial to the understanding of the precise physiological roles of LAP1. The work here 
described proposes novel LAP1 functions through the bioinformatic study of its interactors. 
 
2.2 EXPERIMENTAL SECTION  
 
2.2.1 Collection of associated interactions of LAP1 
 
In order to develop a comprehensive computational analysis of LAP1 interactome, 
experimentally detected protein-protein and protein-nucleic acid interactions were extracted from 
the following public databases:  BioGRID114 (version 3.4.129, consulted Oct 12th 2015), IntAct115 
(version 4.1.8, consulted Oct 13th 2015), mentha116 (version of Oct 13th 2015), I2D117 (version of Oct 
13th 2015), APID118 (version of Oct 13th 2015), HIPPIE119 (version of Oct 13th 2015), NCBI120 (version 
of Oct 13th 2015) and PSICQUIC121 (version 1.4.5, consulted Oct 14th 2015).  
The resulting set of 180 binary interactions includes high and low-throughput data that was 
later manually curated by consulting the corresponding articles. Despite the worth and accessibility 
of protein interaction data from online databases, it comes with limitations. Numerous databases 
(including the ones used in this analysis) contain interactions based on indirect evidence, for 
instance, data mining, genetic interactions, metabolic evidence and colocalization data. The output 
from these eight online databases resulted in the identification of 49 LAP1 interactors. However, 
after analysing the respective publications, 10 interactions were excluded resulting in the 
confirmation of 39 LAP1 interactors (Table II.1 and Figure II.2). 
 
2.2.2 Gene Ontology term enrichment analysis 
Gene Ontology (GO) provides a system of terms to consistently describe and annotate gene 
products122. GO term enrichment analysis (supported by Panther 10.0, released May 15th 2015; 
analysed Oct 15th 2015)123 was performed online using the Search GO data tool (available at 
http://geneontology.org/)124 to enquire for GO terms that are over-represented using the 
annotations regarding biological process and cellular component. The list of genes was pasted into 
the corresponding box to be analysed, choosing Homo sapiens as the species of genes integrated 
in the gene set. GO analysis of LAP1 the interactome was only possible by extrapolating the mouse 
and rat interactions to human. The output retrieved a table that lists significant shared GO terms 
(or parents of GO terms) used to describe the set of genes that users entered on the previous page, 
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the background frequency, the sample frequency, expected p-value, an indication of 
over/underrepresentation for each term, and p-value. The statistical analysis included Bonferroni’s 
correction for multiple testing and a term was reported as enriched if the adjusted p-value is below 
a significance threshold of 0.05. All the input genes were mapped, however two were unclassified: 
TOR3A for biological process ontology and HPDL for cellular component. The p-values were 
corrected for multiple testing using the Bonferroni procedure and transformed by taking the -log10 
for easier visualization. The online GO term enrichment service, retrieved from the online platform 
was stored and analysed as Excel spreadsheet files (Figure II.4). 
 
2.2.3 Software platforms and plugins 
 
Data obtained from the online databases already described were stored and analysed as Excel 
spreadsheet files. The network of LAP1 interactors was built using Cytoscape (3.2.1, freely available 
online at http://www.cytoscape.org/)125. Cytoscape is one of the most popular tools for visualizing, 
integrating, modelling, and analysing molecular and genetic interaction networks125.  
The GeneMANIA plugin (version 3.4.0) was installed using the Cytoscape App Manager 
(Cytopscape plugin can be download at http://apps.cytoscape.org/apps/genemania)126. 
GeneMANIA is a particularly convenient and user-friendly metasearch platform that generates a 
highly correlated signalling network centred on the proteins of interest127. To determine the 
interactions between the LAP1 interactors inside the network, the gene set was introduced into 
GeneMANIA on Cytoscape. Different results can be produced from the same gene list when using 
GeneMANIA. In this case, by only selecting physical interactions data, the network will only show 
genes linked if the proteins in question share a binary interaction established through physical 
experiments127. The integrated network obtained after using GeneMANIA was subsequently 
manually curated with the respective publications to confirm the binary interactions. With the 
editing tools offered by Cytoscape this network was designed to obtain the final result presented 
on Figure II.3.  
BiNGO is a tool used to determine which GO categories are statistically overrepresented in a 
set of genes and outputs a network that allows interactive visualization of results mapped by the 
GO hierarchy128. The BiNGO plugin (version 3.0.3) was installed using the Cytoscape App Manager 
(freely available to download at http://apps.cytoscape.org/apps/bingo)128. In Cytoscape, BiNGO 
outputs a network of the significant GO terms using p-values that were corrected for multiple 
testing using the Bonferroni correction. Each term is size and colour-coded, so that larger nodes 
39 
 
have more genes and darker nodes are more significantly enriched. Intermediate terms that are 
not significant are present as small white nodes128. GO terms are organized in a tree-like structure, 
starting from more general terms at the root (for example, biological regulation) to the most 
specific at the leaves (for example, the regulation of mitotic cell cycle) distributed across the two 
main semantic domains — biological process and cellular location. As GO terms might have more 
than one parent, they are technically structured as a network called a DAG (Figures S1 and S2). 
Ingenuity® Pathway Analysis (IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) is a 
commercially available software program that helps model, analyse and understand complex 
biological and chemical systems. The Ingenuity Knowledge Base is a repository of expertly curated 
biological information. Gene identifications of the previously described interactors were imported 
into the Ingenuity Pathways Analysis (IPA) tool, once more extrapolating the mouse and rat 
interactions to human and excluding viral connections. Function classifications, signal pathways and 
interacting networks were constructed and analysed based on the underlying biological evidence 
from the IPA’s database. The core analysis performed in IPA retrieved seven distinctive functional 
sets: canonical pathways, upstream regulators, diseases and disorders, molecular and cellular 
functions, physiological system development and functions, associated network functions and 
toxicological lists. The output generated through the use of QIAGEN’s Ingenuity Pathway Analysis 
(IPA®, QIAGEN Redwood City, www.qiagen.com/ingenuity) is depicted in Tables II.2-II.5 and Figures 
II.5, S3-S6. Right-tailed Fisher’s exact test was used to calculate the significance of each biological 
function and/or disease assigned, which was reported if the adjusted p-value was below a 
significance threshold of 0.05. 
 
2.3 RESULTS AND DISCUSSION 
 
In order to determine LAP1 interacting proteins a specific approach was adopted, as 
summarized in Figure II.1. Briefly, binary interactions with LAP1 were collected and manually 
curated to obtain the working dataset of LAP1 interactors of (step 2.1, Figure II.1). Subsequent 
integration of the interactions among the listed interactors was performed with GeneMANIA, 
resulting in a more complete prospective network (step 2.2, Figure II.1). GO and BiNGO enrichment 
analysis assisted in ascertaining the most prevalent biological processes and the cellular distribution 
of the interactors (step 2.3, Figure II.1). Finally, by resorting to Ingenuity Pathway Analysis the 
physiological and functional relevance of the selected proteins were explored (step 2.4, Figure II.1). 
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Figure II.1. Methods overview. Schematic representation of the workflow, the steps necessary to integrate the Network 
of LAP1 integrators are depicted.  
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2.3.1 LAP1 interactor’s network 
 
Having curated information retrieved from the set of online databases, all the experimentally 
tested interactions (Table 1) were loaded into Cytoscape 3.2.1125 in order to manually build the 
network of LAP1 interactors (Figure II.2). Of these interactions, 36 were verified in human (grey), 1 
in mouse and rat (blue), 1 only in rat (green) and 3 between human LAP1 and viral proteins (pink 
for HIV-1, red for HRSVA and orange for HHV-4). All the white nodes represent proteins, while RNA 
is denoted with yellow filling. Grey edges signify protein-protein interaction, while protein-RNA or 
RNA-RNA interactions are coloured in black (Figure II.2). 
The bioinformatic analysis retrieved two RNA integrating interactions with LAP1. Of these, 
ELAVL1 is a RNA-binding protein that regulates the stability and translation of numerous mRNAs 
encoding proteins that respond to stress or proliferation129. ELAV-like protein 1 physically interacts 
with TOR1AIP1 mRNA (Figure II.2), possibly promoting stability or influencing translation, in 
response to environmental changes129. Another identified RNA interaction was described for 
WHSC1, which is a histone methyltransferase (MMSET) that has a sequence for ACA11 within an 
intron of its gene130. ACA11 is an orphan box H/ACA class small nuclear RNA (snoRNA) that is 
localized to the nucleoli and integrates a new small nuclear ribonucleoprotein (snRNP) complex that 
is involved in post-splicing intron complexes130. This snRNP is proposed to target other snoRNAs 
intermediates, in particular, snoRNAs hosted within ribosomal protein genes and to bind various 
nucleolar proteins associated with the regulation of RNA processing130. Functionally, ACA11 was 
found to suppress oxidative stress, confer resistance to chemotherapy and increase the 
proliferation in multiple myeloma cells. In the work of Chu and colleagues130, LAP1 was found to 
bind this snoRNA, both sharing binary interactions with HNRNPM, VIM, LMNA and LMNB1 (Figure 
II.2)130. Given the absence of additional functional studies on ACA11, the meaning of its associations 
with LAP1 and its interactors remains unclear. However, the emerging hypothesis is that LAP1 might 
be associated with transcription regulation through the interaction with ACA11 and HNRNPM 
(Figure II.2).  
Moreover, a subset of viral proteins that integrates the LAP1 network, namely tat, 1C and 
LMP2 (Figure II.2) was also identified. Tat is a nuclear regulatory protein crucial for HIV-1 replication 
that also coordinates HIV-1 provirus transcriptional regulation131. Alternatively, RNA viruses like 
HRSV have limited coding capacity, and their proteins often possess multiple functional domains 
with  the ability to interact either with viral or cellular proteins132. This is the case for 1C, which 
binds various human proteins that are associated with transcriptional and cell cycle regulation132. 
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Lastly, Epstein–Barr virus LMP2B isoform colocalizes with LMP2A in perinuclear regions in 
transiently transfected cells133, however LMP2 function in the NE remains unclear. 
Due to the significant role of the NE as a cellular barrier, multiple viral organisms have 
developed the capability to modulate their permeability in order to infect the host cell (reviewed 
in 134). Viruses can modulate NE permeability for different reasons. Some viruses disrupt NE in order 
to transport the viral genome into the nucleus for replication (HIV), while others cause NE 
disruption during nuclear egress of newly assembled capsids (HHV-4) (reviewed in 134). In addition, 
many viruses modulate NE permeability either to destabilize compartmentalization of host proteins 
or to inhibit the nuclear transport of host antiviral response proteins (reviewed in 134). 
 
Table 1. LAP1 interactors obtained from online databases after manual curation of respective publications. 
Gene Protein 
Uniprot 
Accession 
Number 
Species 
Interaction detection 
method 
References 
1C Non-structural protein 1 P04544 
TOR1AIP1 Hs – 1C 
HRSVA 
Affinity Capture-MS 132 
AIFM1 
Apoptosis-inducing factor 1, 
mitochondrial 
O95831 Homo sapiens Affinity Capture-MS 135 
ATM Serine-protein kinase ATM Q13315 Homo sapiens Affinity Capture-MS 136 
Atp1b4 Protein ATP1B4 
Q99ME6 Mus musculus Two-hybrid 
137 
Q9R193 Rattus norvegicus Affinity Capture-WB 
CA10 
Carbonic anhydrase-related protein 
10 
Q9NS85 Homo sapiens Affinity Capture-MS 138 
CANX Calnexin P35564 
Tor1aip1 Mm - 
CANX Hs 
Affinity Capture-MS 139 
CCDC8 
Coiled-coil domain-containing 
protein 8 
Q9H0W5 Homo sapiens Affinity Capture-MS 140 
EGFR Epidermal growth factor receptor P00533 Homo sapiens Affinity Capture-MS 141 
ELAVL1* ELAV-like protein 1 Q15717 Homo sapiens Affinity Capture-RNA 129 
HNRNPM 
Heterogeneous nuclear 
ribonucleoprotein M 
P52272 Homo sapiens Co-fractionation 142 
HPDL 
4-hydroxyphenylpyruvate 
dioxygenase-like protein 
Q96IR7 Homo sapiens Co-fractionation 142 
KLHL15 Kelch-like protein 15 Q96M94 Homo sapiens Affinity Capture-MS 135 
LMNA Prelamin-A/C 
P48678 Mus musculus Affinity Capture-MS 143 
P02545 
Homo sapiens Two-hybrid 144 
Homo sapiens Reconstituted Complex 39 
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Gene Protein 
Uniprot 
Accession 
Number 
Species 
Interaction detection 
method 
References 
Homo sapiens Proximity Label-MS 145 
Lmnb1 Lamin-B1 P70615 Rattus norvegicus Affinity Capture-WB 66 
LMP2 Latent membrane protein 2 Q1HVJ2 
TOR1AIP1 Hs - 
LMP2 HHV-4 
Affinity Capture-MS 146 
LRRK2 
Leucine-rich repeat 
serine/threonine-protein kinase 2 
Q5S007 Homo sapiens Affinity Capture-MS 147 
Mad2l1 MAD2 mitotic arrest deficient-like 1 Q9Z1B5 
TOR1AIP1 Hs - 
Mad2l1 Mm 
Affinity Capture-MS 139 
MAD2L1BP MAD2 mitotic arrest deficient-like 1 Q15013 Homo sapiens Affinity Capture-MS 135 
MDM2 E3 ubiquitin-protein ligase Mdm2 Q00987 Homo sapiens Affinity Capture-MS 148 
NDUFV1 
NADH dehydrogenase [ubiquinone] 
flavoprotein 1, mitochondrial 
P49821 Homo sapiens Co-fractionation 142 
NIT2 Omega-amidase NIT2 Q9NQR4 Homo sapiens Co-fractionation 142 
NTRK1 
High affinity nerve growth factor 
receptor 
P04629 Homo sapiens Affinity Capture-MS 149 
NUP50 
Nuclear pore complex protein 
Nup50 
Q9UKX7 Homo sapiens Co-fractionation 142 
OXCT1 
Succinyl-CoA:3-ketoacid coenzyme 
A transferase 1, mitochondrial 
P55809 Homo sapiens Co-fractionation 142 
PPP1CA 
Serine/threonine-protein 
phosphatase PP1-alpha catalytic 
subunit 
P62136 Homo sapiens 
Affinity Capture-WB 150 
Two-hybrid 151 
PPP1CC 
Serine/threonine-protein 
phosphatase PP1-γ catalytic 
subunit 
P36873 Homo sapiens 
Affinity Capture-WB 150 
Two-hybrid 152 
PTCH1 Protein patched homolog 1 Q13635 Homo sapiens Affinity Capture-MS 138 
RIF1 Telomere-associated protein RIF1 Q5UIP0 Homo sapiens Co-fractionation 142 
SCARNA22** small Cajal body-specific RNA 22 
Gene ID: 
677770 
Homo sapiens Affinity Capture-RNA 130 
S100A16 Protein S100-A16 Q96FQ6 Homo sapiens Co-fractionation 142 
SEPT9 Septin-9 Q9UHD8 Homo sapiens Co-fractionation 142 
tat Protein Tat P04608 
TOR1AIP1 Hs - tat 
HIV- 1 
Affinity Capture-MS 131 
TERF2 Telomeric repeat-binding factor 2 Q15554 Homo sapiens Two-hybrid 153 
TERF2IP 
Telomeric repeat-binding factor 2-
interacting protein 1 
Q9NYB0 Homo sapiens Two-hybrid 153 
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Gene Protein 
Uniprot 
Accession 
Number 
Species 
Interaction detection 
method 
References 
TOR1A Torsin-1A O14656 Homo sapiens 
Affinity Capture-MS/WB 
154 
155 
69 
156 
157 
Reconstituted Complex 
157 
156 
157 
Affinity Capture-MS 67 
TOR1AIP1 Lamina-associated polypeptide 1B Q5JTV8 
Tor1aip1 Mm - 
TOR1AIP1 Hs 
Affinity Capture-MS 139 
TOR1B Torsin-1B O14657 Homo sapiens Affinity Capture-WB 67 
TOR2A Torsin-2A Q5JU69 Homo sapiens Affinity Capture-WB 67 
TOR3A Torsin-3A Q9H497 Homo sapiens Affinity Capture-WB 67 
UBC Polyubiquitin-C P0CG48 Homo sapiens Affinity Capture-MS 
158 
159 
160 
161 
162 
163 
VIM Vimentin P08670 Homo sapiens Affinity Capture-WB 164 
* signify protein-RNA and ** represents RNA-RNA interactions. Hs, Homo sapiens; Mm, Mus musculus; HRSVA, Human 
respiratory syncytial virus A (strain A2); HHV-4, Human herpes virus 4 (Epstein-Barr virus (strain AG876)); HIV-1, Human 
Immunodeficiency Virus 1; MS, mass spectrometry; WB, western blot. 
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Figure II.2. LAP1 interactome built using Cytoscape 3.2.1125. Of these interactions, 36 were verified in human (grey), 1 in 
mouse and rat (blue), 1 only in rat (green) and 3 between human LAP1 and viral proteins (pink for HIV-1, red for HRSVA 
and orange for HHV-4). All the white nodes represent proteins, while RNA is denoted with yellow filling. Grey edges signify 
protein-protein interaction, while protein-RNA or RNA-RNA interactions are coloured with black edges. LAP1 is also able 
to form dimers, which is represented by a self-binding edge. 
 
The mammalian proteins interactions were analysed in the next section with the support of 
GeneMANIA. 
 
2.3.2 Network construction with GeneMANIA 
In order to generate an extended protein-protein interaction network compiled by the set 
of proteins that were obtained previously, excluding RNA interactions and viral proteins, all the 
remaining binary interactions were imported to GeneMANIA126. Network mapping of LAP1 protein 
interactors was only possible by extrapolating the mouse and rat interactions to human. The version 
3.4.0 of GeneMANIA126 was installed into Cytoscape 3.2.1125 enabling network editing and 
manipulation after output. 
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Figure II.3. LAP1 (TOR1AIP1) interactor’s network complemented by the GeneMANIA plugin in cytoscape. Missing 
binary interactions to TOR1AIP1 were added to the GeneMANIA output and are represented in black, while the remaining 
are in pink. Black nodes signify the interactors inserted into the plugin and grey nodes denote GeneMANIA’s additional 
input. LAP1 is also able to form dimers, which is represented by a self-binding edge. 
 
The set of gene IDs was introduced and the functional associative network was set to 
include only physical interactions between proteins. The output includes probable protein 
participants in the interactome of LAP1, extending the network based on a guilt-by-association 
approach that derives predictions from a combination of potentially heterogeneous data 
sources126. The resulting network represents a prospective LAP1 interactome (Figure II.3) that we 
propose to have functional relevance regarding its probable integrative role as a complex assembly 
or stabilization protein. For instance, LAP1 association with itself could be important to form dimers 
that provide a structural link between the nucleoskeleton (lamina) and cytoskeleton across the NE, 
as previously described for SUN domain proteins in the NE (reviewed in 34).  
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The association between MAD2L1 and MAD2L1BP occurs in the mitotic checkpoint complex 
(MCC)165, and both proteins have been proposed to physically bind LAP1 and MAD1L1139 (Figure 
II.3). The MCC inhibits the anaphase-promoting complex/cyclosome (APC/C), which is an E3 
ubiquitin ligase that initiates chromosome segregation166. This inhibition regulates the spindle 
assembly checkpoint (SAC) which is responsible for delaying chromosome segregation until all sister 
chromatids achieve bipolar attachment to the mitotic spindle, ensuring genome stability166. The 
experimental evidence of LAP1 direct interactions with MAD2L1 and MAD2L1BP reinforces the 
early preposition that LAP1 is a key regulator of mitosis39,59,  and strengthens the upcoming 
perspective that LAP1 might be functionally associated to the MCC.  
Human LAP1B was previously described to be phosphorylated on Ser143, in a proline-
directed manner similar to CDKs substrates167, and on Ser164 within the ATM/ATR recognition 
sequence motifs56. Furthermore, rat LAP1B Ser142 (homologous to human LAP1B Ser143) was 
found to be phosphorylated by CDK1-cyclin B168. Indeed, LAP1 seems to be functionally associated 
with several signalling proteins that activate, inhibit and mediate signalling cascades. Among the 
most relevant regulators are protein kinases, in this case comprising EGFR, NTRK1, LRRK2 and ATM 
(Figure II.3). DNA damage events, such as ultraviolet irradiation, result in the nuclear translocation 
of EGFR, in a ligand-independent pathway169. Similarly, LAP1 phosphorylation by ATM on S133, 
S145, S169 and S164 was associated to DNA damage, consolidating the hypothesis that LAP1 might 
be phosphorylated as a cellular response to genotoxic stress136.  
Alternatively, protein phosphatases PP1α (PPP1CA) and PP1γ (PPP1CC) were shown to 
regulate LAP1 by dephosphorylation, forming a complex that was validated in rat brain and cultured 
cells52. This instance reveals the potential role of LAP1 bridging complexes for protein regulation 
through phosphorylation. Moreover, the PP1 regulatory protein CCDC8 (alternatively termed 
PPP1R20) is a core component of the 3-M complex. This complex is required to regulate MT 
dynamics and genome integrity140. Correspondingly, CCDC8 associates to the mRNA splicing 
machinery, in particular to the HNRNP family, which is highly represented in the 3-M 
interactome140.  The above mentioned LAP1 mediated events illustrate the potential dynamic role 
of LAP1 in the regulation of transcription and cytoskeleton mechanisms through the interaction 
with CCDC8 (Figure II.3). 
LAP1 might communicate to the shelterin complex, which is an emerging protein complex 
with DNA remodelling activity that coordinates with DNA repair factors to change the structure of 
the telomeric DNA, thereby protecting chromosome ends (reviewed in 170). This complex is 
composed by TRF1 and TRF2 as double-stranded DNA binding proteins that recognize TTAGGG 
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repeats153. TRF2 in particular is associated to TERF2IP which is then regulated by RIF1 (reviewed in 
170). RIF1 is required for checkpoint mediated arrest in response to DNA damage during the S-phase 
(the intra-S-phase checkpoint)171. This checkpoint can be activated at least by 2 parallel pathways 
involving the ATM kinase171. LAP1 might have a role in assembly or stabilizing this particular subset 
of proteins of the shelterin complex, as it binds to TRF2, TERF2IP, RIF1 and ATM (Figure II.3). 
Telomere associated functions have been previously described for various INM proteins such as 
LMNA, SUN1, LAP1 and BAF (reviewed in 35). 
The relevance of LAP1 interactions regarding biological processes and cellular localizations 
were analysed in the next section with the support of GO enrichment analysis124 and BiNGO128. 
 
2.3.3 GO term enrichment analysis 
 
The online GO Consortium term enrichment service, supported by Panther (available at 
http://geneontology.org/)123,124, was used to conduct a GO term enrichment analysis for the 38 
LAP1 interactors described in table 1, excluding viral connections (tat, 1C and LMP2). In this 
instance, biological process and cellular component GO terms that were enriched among these 
target proteins were sought (Figure II.4). All the IDs of the interactors were mapped with one 
exception, SCARNA22.  
BiNGO128 was alternatively used to build a directed acyclic graph (DAG) network that conveys 
visualization of the enriched terms organized in a tree-like structure, starting from more general 
terms at the root (for example, biological regulation) to the most specific at the leaves (for example, 
the regulation of mitotic cell cycle)128. Each term is coded by size and colour, so that larger nodes 
contain more genes and darker nodes are more significantly enriched. Insignificant intermediate 
terms are denoted as small white nodes128 (Figures S1 and S2). 
Examining the biological processes of the proteins found in the filtered list of interactions 
(Figure II.4A and S1), significant enrichment was observed in the processes of regulation of response 
to DNA damage stimulus, nuclear membrane organization, nuclear envelope organization, cell 
cycle, chaperone mediated protein folding requiring cofactor, chaperone-mediated protein folding, 
nucleus organization, telomere maintenance, cellular component organization, telomere 
organization and cellular component disassembly involved in execution phase of apoptosis. 
Analysing the cellular component that the protein interactors might integrate (Figure II.4B and S2), 
significant and relevant enrichment was found in the nuclear envelope, chromosomal region, 
endoplasmic reticulum lumen, chromosome and telomeric region and lamin filament.  
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This output reinforces the idea that LAP1 might function as a stabilizing element upon the 
formation of multiple complexes as noted before. In particular, integrating a response to DNA 
damage by ATM activation and subsequently participating in telomere regulation as a result, 
through the interaction with RIF1, TERF2IP and TRF2171. Furthermore, there are strong evidences 
that LAP1 intervenes in mitotic regulation via association to MCC complex proteins, as previously 
studied39. The vastly documented relationship with the Torsin family172, resident in the endoplasmic 
reticulum, conveys the chaperone related annotations observed in the enrichment analysis. Finally, 
LAP1 collaboration with the NE cytoskeleton39,172 outputs nuclear membrane organization, nuclear 
envelope organization, cellular component organization and nucleus organization, as some of the 
most prominent biological processes attributed to LAP1. 
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Figure II.4. Significantly enriched Gene Ontology terms from LAP1 interaction network. (A) Biological process and (B) 
Cellular Component. Bonferroni corrected p-values (α = 0.05) were transformed by -log10. 
 
Physiological and functional analysis of the pathways which LAP1’s interactome integrates is 
discussed in the next section resorting to Ingenuity Pathway Analysis. 
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2.3.4 IPA physiological and functional analysis 
 
Gene identifications of the previously described interactors were imported into the IPA 
software, once more extrapolating the mouse and rat interactions to human and excluding viral 
connections. Function classifications, signal pathways and interacting networks were constructed 
and analysed based on the underlying biological evidence from the IPA’s database. The core analysis 
performed in IPA retrieved seven distinctive functional sets: canonical pathways, upstream 
regulators, diseases and disorders, molecular and cellular functions, physiological system 
development and functions, associated network functions and toxicological lists that are depicted 
in Tables II.2-II.6 and Figures II.5, S3-S6. Right-tailed Fisher’s exact test was used to calculate the 
significance of each biological function and/or disease assigned, which was reported if the adjusted 
p-value was below a significance threshold of 0.05. 
IPA reinforced the idea that LAP1 might be communicating with the shelterin complex, as it 
is evident in Table 2, where the top two canonical pathways include “Telomerase signalling” and 
“Telomere Extension by Telomerase”. Furthermore, IPA analysis of physiological system 
development and function identified “Skeletal and Muscular System Development and Function” 
as the most relevant (Table 3). This result is in accordance with the previous described functions of 
LAP1 regarding its association with the Torsin family172.  
Regarding the rank for associated networks in table 4, the analysis is not strict to molecular 
interactions. The result delivered the most pertinent functions of LAP1 interactors, which is 
attributed to “Cell Morphology, Cellular Assembly and Organization, DNA Replication, 
Recombination, and Repair” (Figure II.5). 
Additionally, IPA retrieved BRAC1 as the most probable upstream regulators of LAP1’s 
interactome (Figure S3). This inference is in accordance with the regulation of important 
intervenients of the proposed network for LAP1 interactors (Figure S3), namely EGRF and ATM 
concerning DNA damage events and MAD2L1 which might be activated for mitosis regulation with 
the MCC. Furthermore, table 5 confirms this hypothesis with the identification of “Cell Cycle: G2/M 
DNA Damage Checkpoint Regulation” and “Cell Cycle: G1/S Checkpoint Regulation” as top 
toxicological attributes. 
Lastly, IPA’s analysis of molecular and cellular functions attributed to LAP1’s interactome 
(Table 6) acknowledges “Cell Morphology” and “Cellular Assembly and Organization” as the most 
pertinent, followed by “DNA Replication, Recombination, and Repair”, “Cell Cycle” and “Cell Death 
and Survival”. The networks describing and integrating these functions are available in the 
supplementary figures S4 and S5. By studying these interactions it is possible to deduce the 
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interconnected pathways in which LAP1 might participate, unfolding its crucial role regulating 
nuclear morphology, cell cycle progression and cell survival. 
 
Table 2. Top canonical pathways for LAP1 interactors’ dataset. 
Name p-value Overlap % Overlap 
Telomerase Signalling 2.99E-05 4.00% 4/99 
Telomere Extension by Telomerase 3.28E-04 13.30% 2/15 
HER-2 Signalling in Breast Cancer 3.47E-04 3.90% 3/76 
Glioma Signalling 6.68E-04 3.20% 3/95 
Huntington's Disease Signalling 7.49E-04 1.70% 4/229 
* Overlap represents the percentage of LAP1 interactors integrated in the total number of proteins associated to each 
specific pathway on the IPA Knowledge Base. 
 
 
Table 3. Physiological System Development and Function for LAP1 interactors dataset. 
Name p-value #Molecules 
Skeletal and Muscular System Development and Function 3.61E-03 - 1.82E-06 7 
Tissue Development 3.61E-03 - 1.82E-06 13 
Nervous System Development and Function 3.61E-03 - 3.93E-06 13 
Organ Morphology 3.61E-03 - 3.93E-06 9 
Tissue Morphology 3.61E-03 - 3.93E-06 16 
 
 
Table 4. Top Associated Networks for LAP1 interactors dataset. 
ID Associated Network Functions Score 
1 
Cell Morphology, Cellular Assembly and Organization, DNA Replication, 
Recombination, and Repair 
47 
2 Cancer, Organismal Injury and Abnormalities, Respiratory Disease 32 
3 RNA Post-Transcriptional Modification, Protein Synthesis, Gene Expression 3 
4 Developmental Disorder, Neurological Disease, Behaviour 2 
* Score attributes a numerical value used to rank networks according to how relevant they are to the genes in the input 
dataset. 
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Table 5. Top Toxicological Lists for LAP1 interactors dataset. 
Name p-value Overlap % 
Hypoxia-Inducible Factor Signalling 2.72E-04 4.3 % 3/70 
Mitochondrial Dysfunction 3.90E-03 1.7 % 3/176 
Cell Cycle: G2/M DNA Damage Checkpoint Regulation 3.97E-03 3.8 % 2/52 
Cell Cycle: G1/S Checkpoint Regulation 6.32E-03 3.0 % 2/66 
TR/RXR Activation 1.03E-02 2.4 % 2/85 
* Overlap represents the percentage of LAP1 interactors integrated in the total number of proteins associated to each 
specific pathway on the IPA Knowledge Base. 
 
Table 6. Molecular and cellular functions for LAP1 interactors dataset. 
Name p-value #Molecules 
Cell Morphology 3.61E-03 - 3.18E-11 18 
Cellular Assembly and Organization 3.61E-03 - 3.18E-11 20 
DNA Replication, Recombination, and Repair 3.61E-03 - 1.34E-10 15 
Cell Cycle 3.61E-03 - 9.17E-09 17 
Cell Death and Survival 3.61E-03 - 4.21E-07 20 
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Figure II.1. Network ID 1. IPA Associated Network Functions: Cell Morphology, Cellular Assembly and Organization, DNA 
Replication, Recombination, and Repair. Grey nodes represent proteins that are integrated in the initial dataset, while 
white nodes convey IPA’s supplementary missing proteins. 
 
Ingenuity pathway analysis confirmed the hypothesis that LAP1, besides the functional 
associations with lamins and nuclear morphology, might be a crucial intervenient in cell cycle 
progression and DNA damage responses. These conclusions are in accordance with our prior 
analysis performed with GO and GeneMANIA. 
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2.4 CONCLUSIONS  
 
The integration of multiple bioinformatic tools allowed the development of an intricate study of 
LAP1 interactors. These analyses attribute functions to LAP1 that have not been previously 
described. For instance, various DNA damage response proteins that incorporate or regulate the 
shelterin complex were shown to directly interact with LAP1. This function has been previously 
associated with INM proteins such as LMNA, SUN1, LAP1 and BAF. Additionally, the previously 
described association of LAP1 with mitosis was confirmed through the interaction with MCC. 
Therefore, these and other prospective functions of LAP1 convey the significant role of INM 
proteins in the regulation of multiple cellular processes and disease conditions. 
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2.5 SUPPLEMENTARY DATA 
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  Figure S2. Significantly enriched Gene Ontology terms from LAP1 interaction network concerning Cell Components. Directed 
acyclic graph (DAG) network of the enriched terms organized in a tree-like structure, starting from more general terms at the root 
(for example, macromolecular complex) to the most specific at the leaves (for example, nuclear telomere cap complex) [72]. Each 
term is coded by size and colour, so that larger nodes contain more genes and darker nodes are more significantly enriched. 
Insignificant intermediate terms are denoted as small white nodes [72]. Bonferroni corrected p-values (α = 0.05). 
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Figure S3.  Top Upstream Regulators of LAP1 interactome. IPA retrieved BRAC1 as the most probable upstream regulators of 
LAP1’s interactome, followed by GNA12, GLIPR2, PTTG1 and doxorubicin. Networks for BRAC1 (B) and GNA12 (C) are 
represented. 
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Figure S4. Molecular and cellular functions associated with LAP1 interactors. Singular networks relating morphology of 
the nucleus (A), cell cycle progression (B), and cell survival (C) to each associated member of LAP1 interactome. 
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Figure S5. Merged molecular and cellular functions associated with LAP1 interactors. Integrated networks relating cell 
cycle progression and cell survival (A) or cell survival and mitosis (B) to each associated member of LAP1’s interactome. 
 
 
 
 
 
 
 
 
CHAPTER III – LAP1 AND ITS INTERACTORS IN THE MALE 
REPRODUCTIVE SYSTEM 
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LAP1 was one of the first lamin associated proteins identified40, however its physiological 
function remains poorly understood. Interestingly, LAP1 is probably involved in the regulation of 
the NE structure and mitosis progression, processes that share functional elements with 
spermatogenesis. Therefore the work described in chapter III provides particular insights with 
respect to the localization of LAP1 and some of its interactors during the spermatogenic cycle. The 
results presented in this chapter provide a basis for future studies and will be submitted for 
publication in a manuscript entitled: “Analysis of LAP1 and its interactors throughout 
spermatogenesis”. 
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3.1 INTRODUCTION  
 
Spermatogenesis is a highly complex and particular process of differentiation, which 
implicates germ-cell proliferation and renewal, meiosis, and spermiogenesis under the regulation 
of Sertoli cells. Through this process of differentiation, cells undergo complex morphological and 
biochemical transformations that lead to the formation of highly specialized cells, the haploid 
sperm81. In the proliferation phase, spermatogonia undergo several mitotic divisions to form 
spermatocytes which undergo two meiotic divisions to form haploid spermatids. The latter develop 
into sperm as a result of a complicated metamorphosis involving dramatic structural modifications 
to the shape of their nucleus, compaction of their nuclear chromatin, formation of an acrosome, 
and establishment of a flagellum permitting eventual motility (reviewed in 77,78,80). After leaving the 
seminiferous tubules, sperm is stored along the epididymis and go through maturation. Ejaculation 
follows with sudden activation of their motility. Then, in the female genital tract, especially during 
the ascension towards the ovary through the uterus and fallopian tube, the sperm experience 
capacitation. Finally, acrosome reaction occurs in the immediate vicinity of the oocyte173. 
In mice,  germ spermatogenic cells are characterized according to the presence and 
distribution of heterochromatin: undifferentiated type A spermatogonia; differentiated type A 
spermatogonia; intermediate spermatogonia; and type B spermatogonia84,85. Sequentially, B-
spermatogonia divide by mitosis forming two preleptotene spermatocytes, representing the 
beginning of meiotic prophase86. Preleptotene rest on the basement membrane, but the following 
leptotene, zygotene and pachytene spermatocytes become transit and move through the Sertoli-
Sertoli barrier86. Preleptotene, leptotene and zygotene spermatocytes are located in specific stages 
and are identifiable by routine microscopy, although fixation artefacts might wrongfully lead to the 
observation of these cells attached to the basement membrane. Meiotic cell division occurs in stage 
XII and comprises three phases: meiosis I, the division of diplotene (2n); formation of secondary 
spermatocytes (2n), which are larger than spermatids, but rarely are found as the only 
spermatocyte in a tubular cross section; and meiosis II, the division of secondary spermatocytes 
(2n) to form haploid (1n) round spermatids (reviewed in 75). The total duration of spermatogenesis, 
from the stem cell to the mature spermatid, is approximately 35 days (reviewed in 81).  
Differently, in human, germ cells have a rather different terminology, namely: type A-dark 
spermatogonia; type A-pale spermatogonia; B-spermatogonia; preleptotene, leptotene, zygotene, 
pachytene, and diplotene spermatocytes; secondary spermatocytes; spermatids; and sperm. 
Spermatogonial proliferation and differentiation involve only A pale-spermatogonia, since A dark 
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spermatogonia do not show proliferating activity under normal circumstances and are believed to 
divide only rarely. Indeed, A pale-spermatogonia divide and differentiate into two B spermatogonia, 
which in turn, divide to form preleptotene spermatocytes. Meiosis of spermatocytes includes the 
last synthesis of DNA in preleptotene spermatocytes and 2 meiotic divisions to form spermatids. 
Then, spermiogenesis results in the transformation of a round spermatid to an elongated mature 
spermatid. Finally, spermiation occurs when the structures and connections anchoring a mature 
spermatid to a Sertoli cell disrupt, so that sperm is released into the tubule lumen. In humans, the 
interval between commitment of an A pale-spermatogonium to proliferate and spermiation of 
resulting maturated spermatid averages 74 days (reviewed in77,80). 
Interestingly to this study are morphological changes that occur in spermiogenesis. This 
process includes four crucial phases: Golgi, capping, acrosomal, and maturation (reviewed in 79). 
Together, these highly heterogeneous phases enable the identification of specific stages in the cycle 
of the seminiferous epithelium. Firstly, spermatids have a small, perinuclear Golgi region without 
an acrosomic vesicle or granule. Then, proacrosomal vesicles and granules within the Golgi 
apparatus culminate in the formation of a single, large acrosomal granule within a greater vesicle 
that will indent the nucleus. Capping in round spermatids is characterized by the association of the 
acrosomic granule to the nuclear envelope and by flattening of this vesicle into a small cap over the 
nuclear surface. Later on, the acrosomic vesicle becomes very thin and the granule flattens. Finally 
the acrosome flattens completely over approximately 1/3 of the nuclear surface, and shaping of 
the nuclei begins. Acrosomal steps include migration of the acrosomal system over the ventral 
surface of the elongating spermatid nucleus. The morphological changes in spermatids also involve 
condensation of the chromatin, as the chromosomes are packed more tightly and stain more 
intensely. Maturation displays fewer changes in nuclear shape and acrosomal migration. The 
nucleus continues to condense and the acrosome matures into a thin structure that protrudes at 
the apex but covers nearly all the nucleus, except for the portion connected to the tail. Excess 
cytoplasm is then removed, resulting in the formation of prominent cytoplasmic lobes and residual 
bodies, which contain unused mitochondria, ribosomes, lipids, vesicles and other cytoplasmic 
components (reviewed in 75,79,87).  
Relevant to this study are evident changes that the nuclear envelope undergoes in the course 
of spermiogenesis. Throughout the nuclear shaping and condensation processes, excess nuclear 
membrane is eliminated into the posterior cytoplasm in the form of two continuous sheets at either 
side of the implantation fossa (region where the centrioles connect to the NE). These modifications 
are accompanied by concentration of stacked lamellae along the posterior margin of the NE, 
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nuclear blebbling, and concentration of nuclear pores to the post-acrosomal region. All these 
morphologic changes seem to be associated with the loss of nuclear contents during the gradual 
reduction in nuclear volume (reviewed in 81,90).  
The role of nuclear envelope components has been investigated in relation to the various 
phases of spermatogenesis. Importantly, lamins, LAP2, LBR, and elements of the LINC complex are 
amongst nuclear envelope proteins with more prominent associations to multiple functions in the 
spermatogenic cycle91–97. In spite of being one of the first lamin associated proteins identified40, the 
physiological functions of LAP1 remain poorly understood. Interestingly, LAP1 has been described 
to be involved in the regulation of the NE structure and mitosis progression59, both processes that 
share functional elements with spermatogenesis. A previous study of the expression of LAP1 in 
various human tissues concluded that this protein is differentially present. In fact, testis appeared 
to have a quite equivalent amount of LAP1B and LAP1C isoforms when compared to other tissues49.  
LAP1 interactors analysed in this work include lamin A/C, Lamin B1, PP1, and torsinA. Most 
of these proteins have been previously studied throughout spermatogenesis except for torsinA. 
Lamins have been associated with meiotic chromosome dynamics and with morphological flexibility 
of the nucleus which would be required for nuclear reshaping after meiosis93,104. PP1 is a ubiquitous 
serine/threonine phosphatase, estimated to dephosphorylate about a third of all proteins in 
eukaryotic cells. In mammals there are four PP1 isoforms: PP1α, PP1β/δ and the splice variants 
PP1γ1 and PP1γ2. They possess specific distinct tissue and subcellular distributions: PP1α, PP1β/δ 
and PP1γ1 are widely expressed across mammalian tissues, particularly in brain and PP1γ2 is testis 
enriched174. PP1 isoforms expression profiles in spermatogenesis varies between cell types of the 
adult mice testis. In detail, PP1γ2 is the only isoform present in abundance in secondary 
spermatocytes, round spermatids, and elongating spermatids, whereas for the most part, PP1γ1 
and PP1α expressions are restricted to spermatogonia, pachytene spermatocytes, and somatic 
cells175,176. TorsinA is a member of the AAA+ superfamily of adenosine triphosphatases (ATPases 
associated with a variety of cellular activities). AAA+ proteins participate in numerous functions, 
including vesicle fusion, cytoskeleton dynamics, intracellular trafficking, protein folding and 
degradation and organelle biogenesis177. Mutations in the DYT1 gene are associated with dystonia 
and with the colocalization of torsinA with LAP1 in the NE69. 
Interestingly, the localization of LAP1 in the mitotic spindle, mid-body and centrosomes 
strongly suggests a functional association between LAP1 and these cell cycle related components. 
Specifically, LAP1 colocalizes with γ-tubulin in centrosomes at metaphase and anaphase during 
mitosis. Furthermore, LAP1 depletion seems to be correlated with  the altered centrosome 
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positioning and a decrease in the number of mitotic cells59. Therefore, due the functional 
association of LAP1 in the organization of the mitotic spindle during mitosis55,59 the distribution of 
γ-tubulin in the spermatogenic cycle was also analysed. So, we proposed to examine the localization 
of LAP1 and some of its interactors during the spermatogenic cycle, in order to investigate the 
feasible role of this NE protein in the differentiation of germ cells into sperm. 
3.2 EXPERIMENTAL SECTION 
 
3.2.1 Patient Material and Ethical Approval 
 
For IHC, testicular material was donated after oral informed consent by four patients 
undergoing bilateral orchidectomy as part of prostate cancer treatment (patients URO0179, 
URO0368, URO0059 and URO0126). According to Dutch law, approval of the ethics committee was 
not required, because anonymized tissue samples were used. None of the patients had previously 
received chemotherapy or radiotherapy, and the morphology of the testes showed normal 
spermatogenesis in all cases. Testis biopsies were fixated in 4% paraformaldehyde (PFA) or dilluted 
Bouin solution and embedded in paraffin. All the biopsies and following procedures were 
performed according to regulations from the Academic Medical Centre, in Amsterdam. 
Fresh sperm samples were obtained from patients undergoing routine semen analysis or 
fertility treatments in the Human Reproduction Service at University Hospitals of Coimbra. Patients 
signed informed consent forms and the samples were used in accordance with the appropriate 
Ethical and Internal Review Board of the participating institution. Sperm samples were obtained by 
masturbation after 3-5 days of sexual abstinence and routine seminal samples analysis was 
performed according to the World Health Organization guidelines (WHO)178. All the samples used 
in this study had no detectable leukocytes (or any other round cells).  After liquefaction, sperm cells 
were prepared by direct swim-up and allowed to capacitate in a supplemented Earl’s balance salt 
solution (sEBSS) for at least 3 hours at 37ᵒC under 5% CO2/95% air before starting the experiments. 
Acrosome reaction (AR) was induced by incubating capacitated sperm with 1mM calcium ionophore 
A23187 (Sigma-Aldrich) for 1 hour at 37ᵒC. 
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3.2.2 Animals 
 
Previously obtained paraffin-embedded surplus testes of 8 to 10 weeks old Balb/c mice 
were used for IHC. The animals were used and maintained according to regulations provided by the 
animal ethical committee of the Academic Medical Center, Amsterdam. 
 
 
3.2.3 Cell culture 
 
An immortalized cell line was used to study the localization of LAP1 in spermatogonia. 
Namely, the CG-1 spg (ATCC® CRL 2053™) cell line derived from postnatal day 10 mouse testis. This 
cell line has been described as an intermediate spermatogenic cell type between type B 
spermatogonia and primary spermatocytes. GC-1 cells were maintained in Dulbeco’s Minimum 
Essential Media (DMEM; Gibco) supplemented with 10% fetal bovine serum (FBS) (Gibco) and 100 
U/mL penicillin and 100 mg/mL streptomycin (Gibco). Cultures were maintained at 37°C under 5% 
CO2. Cells were subcultured whenever 80-90% confluence was reached. 
 
 
3.2.4 Antibodies 
 
Several primary antibodies were used to detect multiple proteins analysed in the 
experimental procedures of the dissertation, namely anti-LAP1, anti-lamin A/C, anti-lamin B1, anti-
PP1α, anti-PP1γ, anti-PP1γ2, anti-γ-tubulin, and lastly, anti-torsinA (Table III.1). Additionally, as a 
negative control for IHC, isotypes mouse and rabbit IgGs (Vector Laboratories) were used instead 
of the primary antibody in the corresponding concentrations.  
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Table III.1. Primary antibodies used in order to detect the multiple proteins analysed in ICC and IHC. 
Antibody Antibody type Target Dilution Blocking solution 
Anti-LAP169 
Rabbit, 
polyclonal 
LAP1 
ICC: 1:4000 3% BSA 
IHC: 1:2000 5% BSA + 0.01% BSA-C 
Anti-Lamin A/C (#2023) (Cell 
Signalling) 
Rabbit 
polyclonal 
Lamin A/C IHC: 1:50 3% BSA 
Anti-Lamin B1 (H-90): sc-20682 (Santa 
Cruz Biotechnology, Inc.) 
Rabbit 
polyclonal 
Lamin B1 IHC: 1:100 5% BSA 
Anti-PP1α (CBC2C)179 
Rabbit 
polyclonal 
PP1α IHC: 1:250 5% BSA + 0.01% BSA-C 
Anti-PP1γ (CBC3C)179 
Rabbit 
polyclonal 
PP1γ 
ICC: 1:500 3% BSA 
IHC: 1:500 5% BSA + 0.01% BSA-C 
Anti-PP1γ2  (CBC502)180 
Rabbit 
polyclonal 
PP1γ2 IHC: 1:500 3% BSA 
Anti-acetylated α-tubulin 
Mouse 
Monoclonal 
Acetylated 
α-tubulin 
ICC: 1:250 3% BSA 
Anti-γ-tubulin (GTU-88) (Sigma) 
Mouse 
Monoclonal 
γ-tubulin IHC: 1:2000 5% BSA + 0.01% BSA-C 
Anti-TorsinA (MAB5550) (Millipore) 
Mouse 
Monoclonal 
TorsinA IHC: 1:100 3% BSA 
Anti-COX IV (Thermo Fisher) 
Mouse 
Monoclonal 
COX IV ICC: 1:100 3% BSA 
BSA, bovine serum albumin; BSA-C, acetylated bovine serum albumin; ICC, immunocytochemistry; IHC, 
immunohistochemistry; COX IV, Complex IV Subunit IV. 
 
 
 
Specific secondary antibodies were used in accordance to the particular technique 
performed (Figure III.1) alternating between IHC (Table III.2), and immunocytochemistry (ICC) 
(Table III.3) protocols. 
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Figure III.1. Detection methods using indirect antibody labelling. In each detection method, a visible signal is generated 
following binding of a secondary antibody to a primary antibody, specific for the protein of interest. (A) In colorimetric 
detection, the signal is a coloured precipitate. (B) In fluorescence detection, the antibody is labelled with a fluorophore. 
Adapted from181. 
 
The secondary antibodies used in IHC follow the colorimetric principal (Figure III.1.A). The 
secondary antibody is directly polymerized with horseradish peroxidase (HRP), into compact 
polymers bearing a high ratio of enzymes to antibodies. These polymers demonstrated drastically 
improved detection sensitivity, efficiency and reliability compared to conventional secondary 
antibody conjugates. Direct polymerization also avoids an endogenous biotin reaction. HRP is an 
enzyme that converts the substrate, 3, 3'-diaminobenzidine (DAB), into a brown precipitate that is 
insoluble in alcohol and xylene. As the precipitate accumulates on the sample a coloured signal 
develops and is readily visible by eye. The enzymatic reaction can be monitored and stopped when 
the desired signal over background is reached182. In IHC, the indirect immunofluorescence method 
was applied (Figure III.1.B). In this technique, the secondary antibody carries the fluorophore, and 
recognises the primary antibody which binds the protein of interest183. 
 
 
 
 
Table III.2. Secondary antibodies used in IHC analysis 
Antibody Target 
PowervisionTM Poly-HRP Anti Ms/Rb/Rt IgG Biotin free, one component 
(Leica Biosystems) 
Anti-mouse/rabbit/rat primary 
antibodies 
PowervisionTM Poly-HRP Anti Ms IgG Biotin free, one component (Leica 
Biosystems) 
Anti-mouse primary antibodies 
 
 
B. Fluorescence A. Colorimetric 
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Table III.3. Secondary antibodies used in ICC analysis 
Antibody 
Excitation 
maximum 
(nm) 
Emission 
maximum 
(nm) 
Observed colour 
Alexa Fluor 594 goat anti-mouse IgG (Invitrogen) 590 617 Red 
Alexa Fluor 488 goat anti-rabbit IgG (Invitrogen) 495 519 Green 
ICC, immunocytochemistry. 
3.2.5 Immunohistochemistry 
 
The IHC analysis of human and mouse samples were performed in the Center for 
Reproductive Medicine, Academic Medical Center in Amsterdam, under the supervision of Dr. 
A.M.M. van Pelt PhD. 
Tissue samples from both human and mouse were previously fixated in Bouin´s solution or 
4% PFA and dehydrated using graded ethanol solutions. These graded solutions progressively 
expose the sample to changes in hydrophobicity, minimizing damage to cells.  Leica ASP200S (Leica 
Biosystems), an automated device for tissue dehydration and wax penetration, was used for the 
procedure. Finally, tissue embedding with paraffin had been previously performed, resulting in the 
available paraffin blocks (stored at 4ᵒC) that were used in the following steps.  
 
3.2.5.1 Tissue fixation 
 
An essential part of all histological and cytological techniques is the preservation of cells 
and tissues as they naturally occur. To accomplish this, tissue blocks are usually immersed in a 
fixative fluid. The fixatives employed prevent autolysis by inactivating lysosomal enzymes, and 
stabilize the fine structure, both inside and between cells, by making macromolecules resistant to 
dissolution by water and other liquids. Fixatives also inhibit the growth of bacteria and molds that 
give rise to putrefactive changes184. 
In this work, two fixatives, Bouin and 4% PFA, were tested in order to optimize the staining 
process for each of the primary antibodies used in IHC. Bouin’s solution contains formaldehyde, 
glacial acetic acid and picric acid, in water. The formaldehyde reaction results in the formation of 
cross-linking methylene bridges. Picric acid penetrates tissues rather slowly, coagulating proteins 
and causing some shrinkage, simultaneously dying the tissue yellow. The acetic acid coagulates 
nuclear chromatin and opposes the shrinkage caused by picric acid. The coagulation of nucleic acids 
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is often used in cases where preservation of chromosomes is required. This makes it particularly 
useful in the fixation of the testis if visualization of the meiotic chromosomes is sought. The 
complementary effects of the three ingredients of Bouin’s solution work well together to maintain 
morphology185. Alternatively, 4% PFA, a compound that is obtained through the condensation 
product of formaldehyde, was used as a fixative. As mentioned previously, formaldehyde acts as a 
fixative due to formation of cross-links between proteins known as methylene bridges. Fixation in 
4% PFA results in obvious tissue shrinkage artefacts, especially between seminiferous epithelium 
cells. Shrinkage artefacts are also observed in the central area of the testes fixed in Bouin. 
Additionally, clarity of nuclear detail in testes fixed in Bouin is better compared to 4% PFA184,185. 
Due to the formation of the protein cross-links during fixation from the two fixatives, antigenic sites 
can be masked which can prevent recognition of the antigen by the antibody. This can be overcome 
by adding an antigen retrieval step before IHC protocols. This process can be performed via a heat 
or chemical induced protocols. Both methods break the methylene bridges exposing antigenic sites 
to the antibodies185. 
During the present work, the testis biopsies were fixated 16-18 h in Bouin at 4ᵒC, on a roller 
mixer. Washes were performed three times for 30 min each, with 70% EtOH on a roller mixer at 
4ᵒC, until the solution becomes clear. Alternatively, the testis biopsies were fixated 16-18 h in 4% 
PFA at 4ᵒC, on a roller mixer. First testis were washed in phosphate-buffered saline solution (PBS) 
for 30 min on a roller mixer at 4ᵒC, subsequent washes were performed three times for 30 min 
each, with 70% EtOH on a roller mixer at 4ᵒC. 
 
3.2.5.2 Slicing and mounting paraffin sections on microscope slide 
 
Tissue samples which are embedded into paraffin can be sliced using a microtome. The 
tissue sections can then be mounted on a microscope slide, stained, and examined. The microtome 
was initially adjusted to a thickness of 5 μm per slice. First, it is necessary to securely clasp the 
paraffin block into the block holder. Subsequently, the sections are cut and placed in a water bath 
(37ᵒC) until the section is completely uniform in the water surface. Using adhesive microscope slides 
(KP-Silan adhesive slides grounded-90, Klinipath BV) the sections were fished out of the water bath. 
The microscope slides were then placed on the heating plate at 42ᵒC in order to stretch the tissue 
homogeneously. Lastly, the slides are incubated overnight at 37ᵒC in order to dry the tissue 
completely. 
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3.2.5.3 Histological staining 
 
IHC staining was performed on the 5 μm mouse and human testis sections, previously fixed, 
in Bouin’s solution or 4%PFA, and embedded in paraffin. The tissue sections were then 
deparaffinized in Xylene I and Xylene II, for 3 min each. Hydration followed with sequential 
immersion in 100% EtOH-absolute (2x), 96% EtOH (1x) and 70% EtOH (1x), each for 2 min. After, 
sections were placed in tap water and antigen retrieval was performed in order to uncover hidden 
antigenic sites by breaking the protein cross-links formed by fixation, improving IHC results. 
Thereby, sections were immersed in sodium citrate, pH 6.0, at microwave oven irradiation for 2 min 
at maximum Watt, followed by heating for 10 min at minimum Watt, without boiling. As this 
procedure depends on the specific protein that is being analysed, all the primary antibodies were 
tested in three conditions: no antigen retrieval; one time antigen retrieval; or three times antigen 
retrieval. After optimization, the best staining methods were determined for each primary antibody 
based on the background and specificity when compared between the three conditions mentioned 
above and the IgG staining. Finally, sections were allowed to cool down for 10 min and washed in 
PBS afterwards.   
As the staining protocol relies in the enzymatic activity of HRP (Figure III.1) the endogenous 
peroxidase was blocked, preventing false positive signals. H2O2 blocks endogenous peroxidase, 
therefore tissue sections were incubated with freshly made 0.3% H2O2/PBS for 10 min at room 
temperature (RT), with agitation in the dark. After, samples were washed 3 times for 5 min with 
PBS, slowly shaking. Nonspecific adhesion sites were blocked for 1h at RT, in a humidified chamber. 
The blocking solutions for each antibody were optimized in this work, as it was the first time that 
all the described antibodies were used for colorimetric IHC in the lab (Table III.1). Sections were 
subsequently incubated with the primary antibody or IgG (Vector Laboratories) as negative control, 
for 2h at RT. After washing with PBS, 3 times for 10 min, slowly shaking, the sections were incubated 
in the Poly-HRP secondary antibody. Tissue samples were washed 3 times for 5 min with PBS, slowly 
shaking. Posteriorly, sections were incubated with Bright-DAB (Immunologic) which in the presence 
of peroxidase enzyme, produces a brown precipitate that is insoluble in alcohol and xylene. This 
incubation period varied between 1-4 min depending on the primary antibody used. After staining 
the sections were placed in PBS to stop the reaction and rinsed in demineralised water two times.  
Finally, sections were counterstained 12 sec with freshly filtrated haematoxylin in order to 
visualize the nucleus dark blue or violet. Dehydration of the sections started with immersion in 70% 
EtOH (1x), 96% EtOH (1x), 100% EtOH (2x), Xylene I (1x) and Xylene II (1x), each for 2 min. Sections 
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were then mounted by embedding in Entellan. The slides were examined and pictures were taken 
using an Olympus BX41 bright-field microscope with an Olympus DP20 colour camera.  
 
 
3.2.6 Immunocytochemistry 
 
In the present work, cell culture was performed as described in section 3.2.3 in 6-well plates 
(Corning) with coverslips. Cells were then washed with PBS and 4% PFA was added for 20 min. 
Following fixation, cells were washed trice with PBS and 0.2% Triton-X in PBS was added for 10 min 
to achieve permeabilization. Then, unspecific binding of the primary antibodies was blocked for 1 
h with 3% BSA/PBS. Cells were then incubated for 2 h with the specific primary antibodies depicted 
in Table III.1. Then followed incubation for 1 h with the appropriate fluorescent secondary 
antibodies (Table III.3). Cells were washed thrice with PBS following permeabilization, between 
antibody incubation periods and after incubation with the secondary antibodies. Coverslips were 
then mounted on a microscope slide with VECTASHIELD® Mounting Media with 4',6-diamidino-2-
phenylindole (DAPI) (Vector Laboratories) and visualized by epifluorescence microscopy, using the 
Olympus IX-81 (Olympus, Optical Co. GmbH) motorized inverted microscope equipped with a 
PlanApo 100x/1.40 oil immersion objective lens. Photographs were taken with a Digital CCD 
monochrome camera F-View II (Soft Imaging System). 
Acrosome-reacted sperm cells were fixed with 2% formaldehyde in PBS for 40 min, washed 
with PBS and permeabilized with 1% Triton X-100 in PBS for 20 min. After washing, sperm cells were 
blocked with 1% BSA and 100 mmol/L glycine in PBS for 30 min. After blocking, 100 µl of sperm cells 
was incubated for 2 h at 37oC with the respective primary antibody (Table III.1). Followed this period 
of incubation, sperm cells were washed with  0.1% Triton X-100 in PBS for 30 min. Sperm cells were 
then incubated 1 h at 37oC with the respective secondary antibody (Table III.3) and acrosome 
reacted sperm cells were incubated with PSA-FITC (Pisum Sativum Agglutinin-Fluorescein 
Isothiocynate, 1:200). Sperm cells were then washed with 0.1% Triton X-100 in PBS for 15 min. 
Between washing steps, sperm cells were centrifuged at 1800 rpm during 5 min. Samples were 
mounted on a microscope slide with VECTASHIELD® Mounting Media with DAPI (Vector 
Laboratories) and visualized by epifluorescence microscopy, using the Olympus IX-81 (Olympus, 
Optical Co. GmbH) motorized inverted microscope equipped with a PlanApo 100x/1.40 oil 
immersion objective lens. Photographs were taken with a Digital CCD monochrome camera F-View 
II (Soft Imaging System). Additionally, samples were visualized using a LSM510-Meta confocal 
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microscope (Zeiss) and a 100x/1.4 oil immersion objective. The argon laser lines of 405 nm, 488 nm, 
and a 561 nm DPSS laser were used. Sperm with negative staining with PSA-FITC were considered 
acrosome reacted, as this is an acrosome content marker. 
 
3.3 RESULTS AND DISCUSSION 
 
IHC analysis was performed to investigate the localization of LAP1 and its interactors 
between the different cell types present in sections of mouse and human testis biopsies. 
Afterwards, ICC analysis provided grounds to: the localization of LAP1 in a spermatogonial cell line; 
the characterization of LAP1 distribution in sperm, through the colocalization with COX IV; and the 
investigation of PP1γ and LAP1 interacting profile, by colocalization in sperm. 
 
3.3.1 LAP1 and interacting proteins in the testis 
 
3.3.1.1 LAP1 localization in the testis 
 
After examination of seminiferous tubules representative of all the stages of the 
seminiferous epithelium in mouse, it was possible to observe a differential cellular localization of 
LAP1 between stages of the spermatogenic cycle. For instance, Figure III.2.B clearly shows that the 
subcellular distribution of LAP1 between stages I, VI, VIII and XII is extremely distinct. As the 
negative control (Figure III.2.A) shows only staining in the interstitial space between Leydig cells, it 
is safe to propose that there is positive staining in the NE of peritubular and Sertoli cells. Similarly, 
in germ cells, LAP1 is localized exclusively in the NE of type A spermatogonia, all intermediate 
spermatogonia, B spermatogonia and spermatocytes. However, at the beginning of stage VIII of the 
differentiation process (Figure III.3.A), LAP1 is homogeneously distributed not only in the NE but 
also in the cytoplasm of round spermatids. Interestingly, later in stage VIII (Figure III.3.B) LAP1 
polarizes to one half of the NE of round spermatids, maintaining cytoplasmic presence that is 
characteristic with the beginning of spermiogenesis. Afterwards, in early stage IX (Figure III.4.A), 
the previous indications of a polarization of the signal to one half of the nuclear periphery became 
more evident, with a distinctive increase in LAP1 staining. In Figure III.4.B, this polarization coincides 
with nuclear reshaping and the shifting in directionality of round spermatids, characteristic in the 
progression of spermiogenesis. 
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Figure III.2. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative controls showed staining in the 
interstitial tissue. (B) LAP1 is present in the NE of peritubular, Leydig, Sertoli cells, type A spermatogonia, all intermediate 
spermatogonia, B spermatogonia and spermatocytes. Between round and elongated spermatids LAP1 shows a shift in 
nuclear distribution and an increasing presence in the cytoplasm, concomitant with cellular reshaping. All epithelial stages 
were examined, depicted are stages I, VI, VIII and X. LAP1 polarizes in round spermatids at stage VIII, then presents high 
positive staining in the cytoplasm of stage X, which later decreases staining on stage I. Stages are indicated with Roman 
numerals. 
A
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Figure III.3. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Depicted is early stage VIII with LAP1 present in 
the NE of all germ cells but most prominently distributed around the nucleus of round spermatids. (B) Image of late stage 
VIII where LAP1 concentrates in one half of the NE.  
 
   
Figure III.4. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) In early stage IX, elongating spermatids display 
LAP1 distributed in highly concentrated on side of nucleus, starting nuclear reshaping in form of a U-shape. (B) In stage 
IX, spermatids start displaying a shift in the nuclear direction, pointing to the tubule lumen; simultaneously LAP1 increases 
in the cytoplasm as it expands its volume. 
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These IHC results (Figures III.2-4) provide evidence that LAP1 undergoes dramatic changes in 
its distribution pattern during the initial stages of mouse spermiogenesis. Namely, in stage VIII, 
where round spermatids begin the elongation process, LAP1 becomes highly expressed and most 
importantly, relocates to the centriolar pole of the NE. In addition, LAP1 appears dispersed in the 
cytoplasm, which is quite unusual regarding the typical localization of this INM protein in the NE. In 
early stage IX, nuclear reshaping and simultaneous redirection of round spermatids towards the 
centre of the lumen is concomitant with increasing LAP1 expression both in the NE centriolar pole 
and the cytoplasm. The behaviour of LAP1 is partially comparable to that of LBR, LAP2, Lamins B1 
and B3. In round and elongating spermatids, these NE proteins shift to the nuclear centriolar pole 
but remain only in the nuclear periphery91,96,101. As in the case of LAP1, the significance of the 
redistribution of these NE proteins is presently unknown. However, it is tempting to speculate that 
all of them, including LAP1, might be involved in chromatin reorganization that occurs during 
spermiogenesis. By moving to the posterior pole, the chromatin binding sites at the nuclear 
envelope would contribute to the achievement of the non-random, sperm-specific chromatin 
distribution. Furthermore, previous reports extensively describe that NE proteins, in particular 
lamins and its interactors, play an important role in chromatin dynamics and function (reviewed in 
14).  
Alternatively, it is tempting to speculate that LAP1 might be associated with cytoskeleton 
regulation, as it is described for LINC complexes in spermiogenesis. In fact, Sun3 can participate in 
LINC complex formation through its interaction with Nesprin1. This LINC complex polarizes to the 
posterior pole of the spermatid NE, which is maintained throughout spermatid elongation process. 
There is strong indication that Sun3 and Nesprin1 assemble a spermiogenesis-specific LINC complex 
which polarizes to the posterior pole, thereby facing sites where cytoplasmic manchette MTs 
contact the NE97. The manchette is a transient microtubular structure in the posterior half of the 
nucleus that forms during nuclear elongation. The perinuclear ring of the manchette surrounds the 
base of the elongating nucleus and plays a key role in shaping the nucleus and the spermatid 
head186. LAP1 expression in the nucleus of elongating spermatids seems to coincide with manchette 
formation and function. Taking these facts into account, it is extremely interesting to inquire how 
LAP1 might be regulating or communicating with these cytoskeletal elements and how is it 
connected to the elongating nucleus. 
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In Figure III.5.A, the nucleus of elongating spermatids in late stage IX becomes progressively 
thinner at the centriolar pole, where staining of LAP1 in NE remains highly distinguished. In 
addition, the cytoplasm of elongating spermatids extends into the tubular lumen, which is 
characteristic of residual body development. Concomitantly, the signal of cytoplasmic LAP1 
increases exponentially, with homogenous distribution through the cytoplasm (Figure III.5.B). The 
significance of this quite unusual distribution of LAP1 is currently undisclosed. However, it is 
tempting to explore the possibility that dispersion of LAP1 in the cytoplasm might be a 
behaviourally translated from its distribution in mitosis. Interestingly, LAP1 is distributed 
throughout the cytoplasm of cell in a punctuate pattern throughout mitosis, colocalizing with α-
tubulin in the mitotic spindle and with γ-tubulin in centrosomes. Additionally, it was shown that not 
only is LAP1 important for centrosome positioning near the NE, but also that LAP1 depletion results 
in a decrease of mitotic cells and of the levels of acetylated α-tubulin and lamin B1. These attribute 
a crucial role to LAP1 in the maintenance of the NE structure and progression of the cell cycle59. 
This functional association might be reproduced during spermiogenesis, as dynamic MTs are 
essential for the assembly of various MT-based structures that participate in spermatid 
remodelling, such as manchette formation and nuclear reshaping187. 
 
   
Figure III.5. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. Elongating spermatids in late stage IX show (A) an 
increasing in nuclear narrowing in the centriolar pole and (B) cytoplasmic elongation of spermatids is associated with 
LAP1 increased colouration in the extended cytoplasm. 
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With the beginning of stage X (Figure III.6.A), dramatic nuclear reshaping ensues, with 
progressive narrowing of the nucleus. In this stage, LAP1 is distributed along the nucleus periphery, 
when its reshaping into a needle-like structure begins. Finally, in stage XI (Figure III.6.B), the 
spermatid head forms a distinct protrusion with a sharp angle and the spermatid nuclei become 
thinner, more elongated and begin to stain more intensely, indicating chromatin condensation. 
During stage XI, LAP1 is still circumscribed to one half of the nuclear periphery but its presence 
decreases drastically when compared to the previous stages. This observation could be associated 
with chromatin condensation that occurs at this late stage. As previously proposed, lamin binding 
proteins and lamins themselves have been extensively reported to regulate chromatin tethering 
and reorganization. Once again, in stage XI, the clear presence of LAP1 through the cytoplasm of 
elongating spermatids during the nuclear reshaping process might be related to residual body 
development. 
 
    
Figure III.6. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Early stage X tubules show LAP1 distributed 
along the nucleus, when its reshaping into a needle-like structure begins. (B)  In stage XI, LAP1 circumscription along the 
NE decreases when compared to the previous stages but cytoplasmic staining remains. 
 
 
 
  
A
. 
B
. 
8 μm 8 μm 
81 
 
In stage XII (Figure III.7), meiosis ensues and spermatid elongation continues. LAP1 staining 
that is observed in previous stages around the nucleus is no longer verified. Additionally, there is a 
decrease in cytoplasmic staining. 
Overall, in mouse spermatogenesis, LAP1 presents a peculiar distribution in elongating 
spermatids, from stage VIII onwards. First, it shifts progressively to the centriolar pole of spermatid 
nuclei, then it stains the elongating cytoplasm homogenously before it becomes progressively 
undetectable in fully differentiated mature spermatids (stage VI, Figure III.2). According to these 
evidences, we propose that the progressive disappearance of LAP1 observed in fully elongated 
spermatids may be a consequence of the ending process of chromatin condensation. Moreover, 
LAP1 cytoplasmic staining might be associated with residual body formation which coincides with 
normal cytoplasm outspreading that takes place during spermiogenesis.  
 
 
   
Figure III.7. Immunohistochemical localization of LAP1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A, B) In stage XII tubules with representative 
meiotic cells, LAP1 is present in the cytoplasm of elongated spermatids but with less staining than the previous stages. 
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In human spermatogenesis the seminiferous tubules do not clearly present stage specific 
differentiation. This fact leads to increased difficulties in the distinction of cell types throughout 
spermatogenesis. Moreover, stage identification can be defined in several ways, but inevitably, this 
requires recognition of specific cell types. The appearance of germ cells is highly dependent on 
methods of fixation, embedment, staining, and visualization, being extremely difficult to determine 
by IHC procedures, particularly in cross sections of the human tissue  (reviewed in 79,80). Two 
different fixatives (Bouin, 4% PFA) were tested for IHC analysis of each antibody. The results were 
presented after considering tissue and cellular morphology, background staining and comparison 
to the negative control. 
Previously presented IHC analysis for LAP1 distribution throughout mouse spermatogenesis 
(Figures III.2-7) was performed in testis fixated in Bouin. Despite the fact that Bouin’s fixation leads 
to better conserved tissue morphology, in the case of LAP1 analysis in human testis, fixation with 
4% PFA delivered better staining. In Figure III.8.A, negative controls show very light staining when 
compared to sections immunostainned with LAP1 antibody. Overall, Figures III.8.B-C enabled the 
identification of LAP1 in the NE of in somatic cells namely, peritubular, Leydig, and Sertoli cells. 
Furthermore, germ cell distribution of LAP1 in the NE is restricted to spermatogonia and 
spermatocytes. Elongating spermatids are depicted in Figure III.8.B, showing LAP1 in the centriolar 
pole of the cell, which is concomitant with nuclear reshaping and chromatin condensation. In Figure 
III.8.C it is possible to determine that LAP1 is localized to the centriolar pole of completely elongated 
spermatids, due to the fact that maximum chromatin condensation is evident through darker 
staining by haematoxylin. These results reinforce the hypothesis proposed earlier that LAP1 might 
function as a cytoskeleton regulator of spermiogenesis and that simultaneously might be 
coordinating chromatin tethering and condensation in the process. 
Assessment of LAP1 distribution in human spermatogenesis allowed us to conclude that LAP1 
has an expression pattern quite similar to mouse spermatogenesis. This INM membrane protein 
rests in the NE of germ cells until meiotic division, but its localization shifts in spermiogenesis. 
Throughout elongation of spermatids there is a concentration of LAP1’s signal in the centriolar pole 
(Figure III.9.C), however, later on it is rather difficult to determine if this signal is localized to the 
midpiece of developing sperm (Figure III.9.D) or if it is staining the surplus cytoplasm known as the 
residual body. Due to challenges in visualizing fully matured spermatids in human testis sections, 
ICC analysis was later performed to determine LAP1 localization in sperm. 
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Figure III.8. Immunohistochemical localization of LAP1 in human testis sections fixated in 4% PFA. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative controls showed very light staining. 
(B, C) LAP1 is present in the NE of peritubular, Leydig, and Sertoli cells, spermatogonia and spermatocytes. (B) LAP1 
polarizes in elongating spermatids (asterisk) concomitant with nuclear reshaping and chromatin condensation. (C) LAP1 
is also present in elongated spermatids at the centriolar pole (arrowhead). 
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Interestingly, there is one particular difference between LAP1 localization profile from 
mouse and human sections. As depicted in Figure III.9.B, LAP1 presents a doted feature in the 
cytoplasm of spermatocytes which is quite unusual for this membrane integrating protein. The 
reasons behind this specific localization are unknown but one might speculate if it is related with 
centrosome association. As previously reported59, LAP1 colocalizes with γ-tubulin in centrosomes 
and LAP1 depletion leads to a decline in mitosis. Additionally, it was possible to determine that 
LAP1 is important for centrosome positioning near the NE. All these evidences might explain this 
peculiar localization of LAP1 prior to meiosis in spermatocytes. However, additional studies through 
IHC analysis of colocalization between LAP1 and γ-tubulin in human testis sections might clarify this 
rather erratic behaviour of LAP1. 
 
 
  
  
Figure III.9. Immunohistochemical localization of LAP1 in human testis sections fixated in 4% PFA. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative controls showed no staining. (B, C, D) 
LAP1 is present in the NE of peritubular and Sertoli cells, spermatogonia, spermatocytes and round spermatids. (B) 
Accumulation of LAP1 in a cytoplasmic spot near the nucleus of round spermatids (arrows). (C) LAP1 polarizes in 
elongating spermatids (asterisk) concomitant with nuclear reshaping and chromatin condensation. (D) LAP1 is also 
present in elongated spermatids at the centriolar pole of totally elongated spermatids (arrowhead). 
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3.3.1.2 PP1 isoforms differential distribution in the testis 
 
PP1 has four isoforms (α, β, γ1, γ2), two of which, PP1γ1 and PP1γ2, derive by alternative 
splicing of a single gene, PPP1CC. PP1γ2, expression is confined almost completely to 
spermatogenic cells, being the sole isoform found in mammalian sperm188. Although PP1γ1, the 
other Ppp1cc product, is expressed in many tissues including testis, the only phenotype resulting 
from deletion of Ppp1cc gene is male infertility175. However, it was recently determined that the 
isoform that is essential to infertility is PP1γ2 because the production of sperm capable of 
fertilization in vivo can take place in the complete absence of PP1γ1 expression189. Particularly, PP1α 
is a ubiquitously expressed protein that is functionally associated with mitosis (reviewed in 190). 
Using specific antibodies against PP1α, PP1γ and PP1γ2, a distinct differential distribution 
of these proteins in mouse testicular cells was investigated (Figure III.10). PP1α and PP1γ negative 
controls (Figures III.10.A and C) showed some staining in Leydig and peritubular cells which 
impaired the determination of positive staining in the respective antibodies. No staining was found 
in PP1γ2 negative control (Figure III.10.E). PP1α IHC results (Figure III.10.B) are in agreement with 
previous reports188, as this isoform was found to be localized to the cytoplasm of Leydig and 
peritubular cells, spermatogonia, and pachytene spermatocytes. Concerning PP1γ immunostaining 
in mouse testis (Figure III.10.D), it is possible to determine that this isoform is present in Sertoli, 
Leydig and peritubular cells. In germ cells, it stains the cytoplasm of some spermatogonia and 
meiotic cells. In pachytene spermatocytes and round spermatids, PP1γ is present in the nucleus, 
shifting later onto the cytoplasm of elongating spermatids. Once more, due to the fact that the 
negative IgG control showed some staining in Leydig and peritubular cells, it is not possible to 
confirm the respective staining in sections incubated with PP1α or PP1γ, a fact that has been 
previously established for these somatic cells188. Finally, IHC analysis of PP1γ2 throughout mouse 
spermatogenesis (Figure III.10.F), delivered results which are in conformity with the previously 
reported localization of PP1γ2175 and with the staining presented with PP1γ for both isoforms. 
PP1γ2 seems to be expressed in the nucleus of late pachytene spermatocytes before meiosis. 
During meiosis this isoform is distributed all over the cytoplasm, but afterwards localizes to both 
the nucleus and cytoplasm of round spermatids. Lastly, and most prominently, PP1γ2 is dispersed 
in the cytoplasm of elongating spermatids until excision of residual bodies in the end of 
spermiogenesis.  
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Figure III.10. Immunohistochemical localization of PP1 isoforms in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A, C, E) Negative controls showed staining in 
peritubular cells. (B) PP1α showed strong expression in the cytoplasm of Leydig and peritubular cells, spermatogonia, and 
pachytene spermatocytes. (D) PP1γ staining is present in Sertoli, Leydig and peritubular cells. Additionally, it stains: the 
cytoplasm of some spermatogonia (arrow) and meiotic cells; the nucleus of pachytene spermatocytes and round 
spermatids; and the cytoplasm of elongating spermatids. (F) PP1γ2, concentrates: in the cytoplasm of late pachytene 
spermatocytes only before meiosis; during meiosis is distributed all over the cytoplasm; in the nucleus and cytoplasm of 
round spermatids; and most prominently in the cytoplasm of elongating spermatids.  
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 Despite being thoroughly described in mouse testis, the differential distribution of PP1 
isoforms in human spermatogenesis has not been investigated by IHC. Therefore, using the same 
antibodies that were used in mice, IHC analysis of PP1α, PP1γ and PP1γ2 in human testis was 
performed. No staining was found in all the negative controls for the different PP1 antibodies 
(Figure III.11.A, .C and .E). The IHC analyses of PP1α (Figure III.11.B) revealed an extremely light 
staining, preventing the characterization of this isoform throughout spermatogenesis. However, 
analysis of multiple sections identified PP1α in the nucleus of peritubular and Sertoli cells and 
pachytene spermatocytes. Further optimization is needed for the confirmation of these results. In 
the case of PP1γ (Figure III.11.D) staining is present in the nucleus of Sertoli, Leydig cells, pachytene 
spermatocytes and round spermatids. Lastly, PP1γ2 (Figure III.11.F) displays a much stronger signal 
when compared to the other isoforms analysed. This isoform concentrates in the nucleus of late 
pachytene spermatocytes immediately before meiosis. Later on, PP1γ2 shifts from the nucleus and 
cytoplasm of round spermatids to the centriolar pole of elongating spermatids (Figure III.11.F, right 
ROI) and completely elongated spermatids (Figure III.11.F, left ROI). 
 The implications of the distribution of PP1 isoforms have been previously described for 
mouse testis175,176. Considering the results obtained for PP1α in mouse testis (Figure III.10.B), it 
would be reasonable to speculate that the presence of this protein in the initial stages of 
spermatogenesis might be related to its prominent role in mitosis174, as the most robust signal is 
conferred to spermatogonia. The expression pattern of PP1γ is quite similar between 
spermatogenic cells in mouse (Figure III.10.D) and human testis (Figure III.11.D). In both specimens, 
there is specific staining in somatic cells, namely Sertoli and Leydig cells. This is, partially, in 
accordance with previous reports that acknowledge that PP1γ1 staining in mice is evident in Sertoli 
cells176. Moreover, PP1γ is also present in some spermatogonia (Figure III.10.D, arrow), whereas 
this particular staining was absent in developing germ cells stained with PP1γ2 (Figure III.10.F). In 
fact, PP1γ2 expression in mice (Figure III.10.F) and human testis (Figure III.11.F) is detected in 
pachytene spermatocytes and in all subsequent stages of post-meiotic developing germ cells. 
Therefore it is reasonable to conclude that pre-meiotic and somatic staining might be conferred to 
PP1γ1. These staining patterns also confirm observations from earlier studies175,176.  
 Due to these results, it is interesting to consider that impaired spermatogenesis and male 
infertility could be influenced by the combined loss of both PP1γ isoforms in testicular somatic cells 
(PP1γ1) and developing germ cells (PP1γ2). 
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Figure III.11. Immunohistochemical localization of PP1 isoforms in human testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A, C, E) Negative controls showed no staining. (B) 
Staining not clear. PP1α seems to be expressed in the nucleus of peritubular and Sertoli cells and pachytene 
spermatocytes. (D) PP1γ staining is present in the nucleus of Sertoli, Leydig cells, pachytene spermatocytes and round 
spermatids. (F) PP1γ2, concentrates in the nucleus of late pachytene spermatocytes, and of germ cells ranging from the 
nucleus and cytoplasm of round spermatids progressively shifting to the centriolar pole of elongating spermatids (right 
ROI) and mature spermatids (left ROI). 
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 Global analysis regarding the distribution of PP1γ2 in mouse testis reveals a peculiar 
pattern, one that is similar to LAP1 throughout spermatogenesis. As depicted in Figure III.12.A, 
PP1γ2 signal in the cytoplasm appears quite noticeably in stage VIII round spermatids, which is also 
the case for LAP1. As elongation proceeds in stage IX, PP1γ2 relocates to the centriolar pole, still 
distributed through the cytoplasm but also evident in one half of the NE (Figure III.12.B, .C), 
concomitant with LAP1 staining. Later on, stage X spermatids (Figure III.12.D) present nuclear 
reshaping and cytoplasm elongation, which persistent with PP1γ2 immunostaining in the NE and 
cytoplasm, similar to LAP1. After complete narrowing of the nucleus into a needle like shape, PP1γ2 
is only present in the extended cytoplasm of stage XI spermatids (Figure III.12.E). Finally, after 
meiosis, elongated spermatids remain stained with PP1γ2 only in the cytoplasm (Figure III.12.F). All 
the stages and respective staining described for PP1γ2 possibly colocalize with LAP1 as both 
proteins have an extraordinary similar expression pattern throughout spermiogenesis. This 
hypothesis can be easily clarified through future immunofluorescent colocalization of LAP1 and 
PP1γ2. 
 When exploring the putative interaction between LAP1 and PP1γ2 in spermiogenesis, 
functional perspectives arise. LAP1 has been previously identified as a PP1γ substrate49,52. 
Therefore, the overlapping localization of both proteins throughout spermiogenesis might be 
associated to the shifting of LAP1 from the NE to the cytoplasm, and its activity there. The 
phosphorylation status of LAP1 throughout mitosis has been shown to vary. In fact, LAP1 has been 
shown to be phosphorylated during both interphase and mitosis but appeared to be most highly 
phosphorylated during mitosis, consistent with previous reports for NE proteins18,59. Additionally, 
given that both proteins have important roles in the process of mitosis regarding MT dynamics59,190, 
there is an additional putative significance to this association in the spermatid elongation process.  
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Figure III.12. Immunohistochemical localization of PP1γ2 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. PP1γ2, concentrates in the nucleus pachytene 
spermatocytes, and is prominently expressed in the cytoplasm of germ cells ranging from late pachytene spermatocytes, 
round spermatids to elongating spermatids and sperm. Depicted are stages concomitant with the expression, and 
possible colocalization, of LAP1. (A) Stage VIII round spermatids stain with PP1γ2. (B, C) High positive staining in the 
cytoplasm of stage IX spermatids. (D) In stage X nuclear reshaping occurs, accompanied by cytoplasmic extension and 
high positive staining of PP1γ2. (E) Prior to meiosis, in stage XI, PP1γ2 distinctively stains the nucleus of late spermatocytes 
and the cytoplasm of elongating spermatids. (F) In stage I, round spermatids are equally stained in the nucleus and 
cytoplasm while elongated spermatids remain stained only in the cytoplasm.  
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3.3.1.3 Lamin localization in the testis 
 
Nuclear lamins are important structural protein components of the nuclear envelope. The 
composition and properties of the nuclear lamina of spermatogenic cells differ significantly from 
those of somatic cells in the same species. Alsheimer and colleagues have extensively investigated 
the expression of lamins and lamin-binding proteins throughout spermatogenesis91–93,97,100,101,103,104. 
Extensive study during the course of decades revealed that among somatic lamins, lamin B1 is the 
only one that is expressed during spermatogenesis, concluding that lamins A, C, and B2 are not 
present in any phase of this differentiation process. Instead, two short gametogenesis-specific 
lamins appear at different stages to become part of a therefore specifically modified lamina: A-type 
lamin C2 that is selectively expressed during meiotic prophase I100 and lamin B3, a short lamin B2 
isoform24, whose expression is restricted to post-meiotic stages. 
However, recent reports show that lamin A/C is expressed in the mouse testis during the 
different stages of spermatogenesis and in mature sperm99, contrary to what was previously 
thought. Lamin A/C was found to be localized to the acrosome during spermiogenesis, from round 
spermatids until mature sperm, and that the decreased expression of lamin A/C caused a significant 
increase in sperm head abnormalities. Partially, our results seem to be in agreement with these 
observations, as lamin A/C is expressed most prominently in the acrosome of late spermatids 
(Figure III.13.B, .E, .F). Moreover, in the initial stages of spermatogenesis, spermatogonia (Figure 
III.13.F, arrow) do not seem to contain lamin A/C, as previously reported. A distinct result from the 
literature is the presence of lamin A/C in the NE of pachytene spermatocytes and Sertoli cells (Figure 
III.13.C, asterisk) and in the tail of elongated spermatids (Figure III.13.D). Additionally, staining is 
visible in the NE of Leydig and peritubular cells (Figure III.13.B). 
 Lamin B1 expression in mouse testis has been previously attributed to one half of the 
nuclear periphery of late round spermatids, which later became concentrated to a spot in the 
centriolar pole of elongated nuclei98. The results obtained after our IHC analysis show that lamin B1 
(Figure III.14.B) is present in the NE of peritubular, Leydig and Sertoli cells, spermatogonia and 
round spermatids. As depicted in Figure III.14.C, lamin B1 also specifically stains the NE of pachytene 
spermatocytes. Lastly, lamin B1 seems to appear dispersed in the cytoplasm of meiotic cells (Figure 
III.14.D, arrowhead). Together, the results obtained in this work partially disagree with previous 
reports. No staining was obtained in germ cells after round spermatids, as it was described for lamin 
B198. However, due to the fact that the localization of lamin B1 in spermiogenesis is constrained to 
a small part of the NE maybe it might only be detectable by immunofluorescence. 
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Figure III.13. Immunohistochemical localization of lamin A/C in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin.  (A) Negative controls showed staining in the 
cytoplasm of interstitial tissue. (B) Tubule stained for lamin A/C showing concentration in the NE of peritubular and Leydig 
cells and most evidently mature spermatids acrosome. (C) Light staining of the NE of Sertoli cells and pachytene 
spermatocytes (asterisk). (D) Elongated spermatids show positive staining in the axoneme. (E, F) Specific coloration in the 
acrosome of elongated spermatids, (F) however spermatogonia appear to have no lamin A/C (arrow). 
 
 
 
 
 
A
. 
B
. 
C
. 
D
. 
E
. 
F
. 
8 μm 8 μm 
8 μm 8 μm 
20 μm 20 μm 
* 
93 
 
  
  
Figure III.14. Immunohistochemical localization of lamin B1 in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative control showed staining in interstitial 
tissue. (B) Lamin B1 is present in the NE of peritubular, Leydig and Sertoli cells and spermatogonia. (C) Lamin B1 is clearly 
present in pachytene spermatocytes (asterisk) and round spermatids (arrow). (D) Meiotic cells (arrowhead) clearly 
present positive staining in the cytoplasm. 
 
 Throughout human spermatogenic cycle, the presence of lamin A/C has not been 
detected191. Our IHC results for lamin A/C (Figure III.14.B) demonstrate that lamin A/C is present in 
the NE of peritubular, Leydig and Sertoli cells, pachytene spermatocytes and round spermatids. 
Conversely, a previous study of lamin B1 in human testis191 concluded that this isoform is present 
at the nuclear periphery of round spermatids, in the area that opposed to the acrosome. During 
spermatid maturation, lamin B1 progressively transfers to the posterior pole of the nucleus as the 
acrosome spreads. In elongated spermatids, lamin B1 is located at the posterior pole of the nuclei. 
This report is extremely similar to our results for lamin B1 in human testis. Lamin B1 (Figure III.14.D) 
is clearly expressed in the NE of peritubular, Leydig and Sertoli cells, late pachytene spermatocytes 
and round spermatids. Additionally, Lamin B1 staining in (Figure III.14.E) round and (Figure III.14.F) 
elongated spermatids at the centriolar pole is observed. Interestingly, when compared with the 
fixation in Bouin, human testis fixated in 4% PFA present lamin B1 staining more clearly in the 
centriolar pole of elongated spermatids, as depicted in the ROI (Figure III.14.H).  
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Figure III.15. Immunohistochemical localization of lamin A/C and lamin B1 in human testis sections fixated in Bouin 
and 4% PFA. Positive immunostaining in brown colour, counterstaining with haematoxylin. (A, C, G) Negative controls 
showed no staining.  (B) In human testis fixated in Bouin, lamin A/C is present in the NE of peritubular, Leydig and Sertoli 
cells, pachytene spermatocytes and round spermatids. (D) In human testis fixated in Bouin, lamin B1 is clearly expressed 
in the NE of peritubular, Leydig and Sertoli cells, late pachytene spermatocytes and round spermatids. (E, F) Lamin B1 
staining in (E) round and (F) elongated spermatids at the centriolar pole is observed. (H) When compared with the fixation 
in Bouin, in human testis fixated in 4% PFA lamin B1 is more clearly expressed in the centriolar pole of elongated 
spermatids, as depicted in the ROI.  
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There is mounting evidence that the nuclear lamina plays a crucial role in spermatid 
differentiation during spermiogenesis. With this work it was possible to conclude that lamin A/C 
retains a quite peculiar expression pattern in mouse testis, which is quite different from human. In 
mouse, lamin A/C is expressed most prominently in the acrosome and tail of late spermatids, 
additionally staining the NE of pachytene spermatocytes, Leydig, peritubular and Sertoli cells. In 
human, the same isoform seems to be present in the NE of peritubular, Leydig and Sertoli cells, 
pachytene spermatocytes and round spermatids. 
Concerning lamin B1, our results, supplemented with similar literature, enable the 
conclusion that lamin B1 is continuously present throughout spermatogenesis. In pre-meiotic 
stages it seems to localize in the NE, during meiosis it is dispersed in the cytoplasm of meiotic cells, 
but afterwards concentrates to the centriolar pole of elongated nuclei98. In human, our results seem 
to agree with previous studies. Lamin B1 is clearly expressed in the NE of late pachytene 
spermatocytes and round spermatids. In post-meiotic cells, lamin B1 concentrates in the periphery 
of round spermatids, distributed opposed to the acrosome. During spermatid elongation, lamin B1 
transfers to the posterior pole of the nucleus, finally localizing in the centriolar pole of elongated 
spermatids. 
Taken together, these results seem to indicate that the role of nuclear lamina is to increase 
the flexibility of the nucleus in order to enable the intense nuclear remodelling that occurs during 
spermiogenesis, either in the acrosome cap (lamin A/C) or at the centriolar pole (lamin B1). 
Additionally, the presence at the centriolar pole of lamin B1 seems to be similar to LAP1 distribution 
in the NE, during mouse and human spermiogenesis. Once again, these results accentuate the 
putative role of LAP1 and lamins in the regulation of chromatin condensation and simultaneous 
nuclear reshaping, during the process of spermiogenesis. 
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3.3.1.4 γ-tubulin in spermatogenesis 
 
Tubulin dimers are polymerized into microtubules at the microtubule organising centres 
(MTOCs). Physiological nucleation requires a nucleator that stabilizes a small microtubule seed 
composed of multiple heterodimers. The best known nucleator, γ-tubulin, localises to all known 
cellular MTOCs and forms a γ-tubulin ring complex (γ-TuRC), which is a highly efficient nucleation 
site. The most prominent and best known MTOC in cells is the centrosome, consisting of a pair of 
centrioles surrounded by pericentriolar material (PCM). In spermiogenesis, the spermatid nucleus 
polarizes to one side of the cell, as it begins the process of nuclear compaction and reshaping which 
is facilitated by the manchette. The manchette is a skirt-like structure of microtubules that project 
from a perinuclear ring, just below the acrosome, into the spermatid cytoplasm. The origin of the 
manchette microtubules is a matter of debate. It has been assumed that the perinuclear ring, from 
which the manchette microtubules emanate, is the MTOC. However, this hypothesis has not been 
proven yet187. 
The distribution of γ-tubulin in mouse has been previously described by  
immunofluorescence192, making cell identification rather difficult, but sharing similarities with our 
results. As depicted in Figure III.16.B, γ-Tubulin stains peritubular and Leydig cells. Interestingly, in 
in the initial phases of the spermatogenic cycle, germ cells ranging from spermatogonia until late 
spermatocytes stain homogenously through the cytoplasm. However, from meiosis onwards, γ-
tubulin concentrates in dots at the centriolar poles (Figure III.16.B, asterisk). In Figure III.16.C, 
cytoplasmic distribution of γ-tubulin in spermatogonia, leptotene and pachytene spermatocytes is 
evident. However, round spermatids present only one dot at the centriolar pole. When elongation 
proceeds, spermatids maintain a centriolar dot, near the nucleus facing the tubule lumen (Figure 
III.16.D). In completely elongated spermatids one dot is also present at the centriolar pole. Lastly, 
in dividing cells two dots are observed at the centriolar regions. 
Throughout human spermatogenesis, γ-tubulin stains quite similar from mouse testis. As 
depicted in Figure III.17.B, γ-Tubulin stains centrioles in peritubular and Leydig cells. Additionally, 
in germ cells from initial phases of the spermatogenic cycle, ranging from spermatogonia until late 
spermatocytes, staining appears distributed through the cytoplasm. As depicted in arrows in 
Figures III.17.C and .D, after meiosis γ-tubulin concentrates in dots at the centriolar poles, while 
also being distributed homogenously through the cytoplasm of round spermatids. In completely 
elongated spermatids (Figure III.17.D), γ-tubulin concentrates in a dot at the centriolar pole. 
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Figure III.16. Immunohistochemical localization of γ-tubulin in mouse testis sections fixated in Bouin. Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative control showed staining in peritubular 
cells. (B) γ-Tubulin stains peritubular and Leydig cells. Additionally, in germ cells from initial phases of the spermatogenic 
cycle, ranging from spermatogonia until late spermatocytes, staining appears distributed through the cytoplasm. From 
meiosis (asterik) onwards, γ-tubulin concentrates in dots at the centriolar poles. (C) Cytoplasmic distribution of γ-tubulin 
in spermatogonia, leptotene and pachytene spermatocytes is evident; in turn, round spermatids present one dot only at 
the centriolar pole. (D) In elongating spermatids a centriolar dot is clearly observed. (E) In completely elongated 
spermatids one dot is present at the centriolar pole. (F) Dividing cells confirm that the dots observed are the centriolar 
regions. 
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Figure III.17. Immunohistochemical localization of γ-tubulin in human testis sections fixated in Bouin.  Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative control showed no staining. (B) γ-
Tubulin stains centrioles in peritubular and Leydig cells. Additionally, in germ cells from initial phases of the spermatogenic 
cycle, ranging from spermatogonia until late spermatocytes, staining appears distributed through the cytoplasm. (C, D)  
After meiosis, γ-tubulin concentrates in dots at the centriolar poles, while it is also distributed homogenously through the 
cytoplasm of round spermatids (arrows). (D) In completely elongated spermatids γ-tubulin (asterisk) concentrates in a 
dot at the centriolar pole. 
 
 The comparative study of expression profiles of LAP1 and γ-tubulin, in human 
spermatogenesis, reveals an interesting association. The cytoplasmic distribution of γ-tubulin in 
round and elongating spermatids coincides with LAP1 localization in the same cells. Additionally, 
the cytoplasmic presence of γ-tubulin in elongating spermatids is not reproduced by γ-tubulin in 
the mouse testis, and has not been previously described. Additionally, in fully elongated spermatids 
the dotted pattern at the centriolar pole coincides between LAP1 and γ-tubulin staining in mouse 
and human testis. Further analysis of this association might clarify and reveal interesting functions 
for LAP1 regarding manchette organization. Moreover, future studies might contribute to the 
clarification of the present debate regarding the origin and organization of the manchette 
microtubules. 
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3.3.1.5 TorsinA localization in the testis 
 
Torsin A is a chaperone protein that mediates conformational changes in target proteins. 
Interestingly, the torsin protein family has never been described in the spermatogenic cycle. 
General observation of the results obtained (Figure III.18.B) determined that torsinA presents a 
diffused expression in peritubular cells, Sertoli cells and early pachytene spermatocytes (Figure 
III.18.B, asterisk). Afterwards, torsinA concentrates in a cytoplasmic granule of mid and late 
pachytene spermatocytes (Figure III.18.B). In mid pachytene spermatocytes (Figure III.18.C, arrow) 
a highly concentrated staining is observed as granule in the cytoplasm, with no shape. Late 
pachytene spermatocytes (Figure III.18.D, ROI) have a less dense staining than mid pachytene 
spermatocytes, and the granule acquires a circular shape. The volume of this cytoplasmic granule 
seems to later decrease exponentially in round spermatids (Figure III.18.B, arrowheads).  
 
  
   
Figure III.18. Immunohistochemical localization of torsinA in human testis sections fixated in Bouin.  Positive 
immunostaining in brown colour, counterstaining with haematoxylin. (A) Negative control showed no staining. (B) 
General observation determined that torsinA is expressed in peritubular cells, Sertoli cells and early pachytene 
spermatocytes (asterisk); posteriorly, it is concentrated in a cytoplasmic granule of mid and late pachytene spermatocytes 
and some round spermatids (arrowheads). (C) In mid pachytene spermatocytes (arrow) a highly concentrated staining is 
observed as granule in the cytoplasm, without shape. (D) Late pachytene spermatocytes (ROI) have inferior staining than 
mid pachytene spermatocytes, and the granule acquires a circular shape.  
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We propose that this granule is the Golgi apparatus. The Golgi apparatus is a subcellular 
organelle that functions in glycosylation, processing, and sorting of newly synthesized proteins 
being transported from the ER. Throughout spermatogenesis, the Golgi apparatus is highly 
important for the formation of the acrosome. In mammals, acrosome biogenesis begins with the 
fusion of proacrosomal granules synthesized by the Golgi apparatus in pachytene spermatocytes. 
In these cells, the Golgi apparatus forms an eccentric sphere surrounding the proacrosomal 
granules193.  
TorsinA is involved in several functions, including protein folding and degradation, 
membrane trafficking, DNA replication and repair, mitosis and cytoskeletal regulation. Typically, 
this protein resides in the NE, however, it seems that in pre-meiotic phases of spermatogenesis it 
localizes to the Golgi apparatus177,194. In order to determine the role of torsinA throughout 
spermatogenesis it would be interesting to confirm by immunofluorescence the colocalization of 
torsinA with a Golgi marker. Additionally, it would be interesting to study the localization of this 
protein during spermiogenesis using mouse testis. We attempted this final procedure, but due to 
antibody specificity the IHC results were not favourable and will not be presented. 
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3.3.2 LAP1 distribution in spermatogonia and sperm 
 
LAP1 subcellular localization was investigated in spermatogonial cells through ICC. GC-1 spg 
is a mouse spermatogonial cell line that corresponds to a stage between spermatogonia type B and 
primary spermatocytes, based on its characteristics in phase contrast and electron microscopy195.  
In conformity with the IHC study of LAP1 in mouse spermatogenetic cells, overall ICC 
analysis determined the localization of LAP1 in the NE of spermatogonia type B and primary 
spermatocytes. Depicted in Figure III.19 is a typical phenotype described for commitant 
spermatogonia, in this case, B spermatogia. When a spermatogonium divides, telophase is 
incomplete, leaving an open area of cytoplasmic continuity called a cytoplasmic bridge. Bridges 
allow sharing of gene products between cells of a clone. If gene products in adjacent cells are 
shared, cellular activities become synchronized, resulting in a synchronized development84. 
 
  
  
Figure III.19. Subcellular distribution of LAP1 in mouse spermatogonia. Immunocytochemistry in GC-1 spg cells was 
performed using specific antibodies to endogenous LAP1 (green) and acetylated α-tubulin (red). Photographs were 
acquired by epifluorescence microscopy. Negative control showed no staining (data not shown). 
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IHC analysis of human testis section in this work revealed that throughout the elongation 
of spermatids, LAP1 is concentrated at the centriolar pole. However, we found it difficult to 
determine if this signal is localized to the midpiece of developing sperm (Figure III.9.D) or if it was 
staining of the surplus cytoplasm known as the residual body. Consequently, we proceeded to 
investigate the localization of LAP1 in sperm (Figure III.20).  
Subcellular localization of LAP1 in human sperm revealed differential staining prior to and 
after acrosome reaction. As depicted in Figure III.20, the acrosome of non-reacted sperm is stained 
with PSA-FITC. In this case, LAP1 is localized to the post-acrosomal region and the midpiece. After 
acrosome reaction, LAP1 is distributed along the post-acrosomal sheath and the midpiece. The 
significance of these results is most likely associated to motility purposes considering the 
distribution of LAP1 in the midpiece. During sperm movement, the adenosine triphosphate (ATP) 
needed to whip the flagellum and propel the sperm comes from rings of mitochondria located in 
the midpiece of sperm. In mammals, there is a layer of dense fibres interposed between the 
mitochondrial sheath and the axoneme that stiffens the sperm tail. Since the thickness of this layer 
decreases toward the tip, the fibres probably prevent the sperm head from being whipped around 
too suddenly196. Due to the continuity of LAP1 staining between the midpiece and the post-
acrosomal region it is reasonable to deduce that LAP1 might be associated to the maintenance of 
these structures. 
Considering the differential staining of LAP1 between non-reacted and acrosome-reacted 
sperm, it is interesting to consider the membrane interaction between sperm and the oocyte. In 
acrosome-reacted sperm, the forward part of the sperm head is covered only by the former inner 
membrane of the acrosome. The post-acrosomal region is crucial for sperm to bind to the oocyte196. 
Therefore, these ICC might reveal an unknown association between LAP1 and the fertilization 
process. 
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Figure III.20. Subcellular distribution of LAP1 in human sperm. Immunocytochemistry in human sperm cells was 
performed using a specific antibody to endogenous LAP1 (green). Photographs were acquired by epifluorescence 
microscopy. Negative control showed no staining (data not shown). Sperm cells with negative staining in the nucleus with 
PSA-FITC (green) were considered acrosome reacted. 
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 Identification of LAP1 in the midpiece prompted the colocalization study between LAP1 and 
a midpiece marker, Cytochrome c oxidase IV (COX IV). It is well-established that mitochondria 
collect around the flagellum near the base of the nucleus and become incorporated into the 
midpiece of sperm196. COX IV is a known element of the mitochondrial respiratory chain. It is a 
multi-subunit enzyme complex that couples the transfer of electrons from cytochrome c to 
molecular oxygen and contributes to a proton electrochemical gradient across the inner 
mitochondrial membrane197. As depicted in Figure III.21 LAP1 shows colocalization with the 
midpiece. These results reinforce the hypothesis that LAP1 is associated with the structures 
responsible for motility in sperm, making it a worthy candidate for future studies regarding sperm 
development and activity. 
 
     
Figure III.21. Subcellular distribution of LAP1 and COX IV, in human sperm. Immunocytochemistry in human sperm cells 
was performed using specific antibodies to endogenous LAP1 (red) and COX IV (blue). Immunolocalization of LAP1 and 
COX IV is observed. Z-Projections of stack images were acquired by confocal microscopy. Negative control showed no 
staining (data not shown). Sperm cells with negative staining in the nucleus with PSA-FITC (green) were considered 
acrosome reacted. 
 
 
Lastly, the possible regulation of LAP1 in sperm was investigated. Given the known 
regulatory role of PP1γ on LAP149,52 we inquired if these proteins possibly interact in sperm. This 
experiment (Figure III.22) revealed that acrosome-reacted sperm exhibit partial colocalization 
between LAP1 and PP1γ, which is apparent in the merged images of both proteins. PP1γ2 is the 
only isoform found in mammalian sperm188 and it is known to regulate sperm motility198. Therefore 
it is safe to consider that this putative regulatory interaction occurs between PP1γ2 and LAP1. 
Additionally, the fact that both PP1γ2 and LAP1 are present in the equatorial and posterior 
(respectively) regions of the head, suggests a functional role of both proteins in the acrosome 
reaction. Hence, future studies regarding the functional role of this interaction in acrosome reaction 
and fertility should be pursued. 
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Figure III.22. Subcellular distribution of LAP1 and PP1γ, in human sperm. Immunocytochemistry in human sperm cells 
was performed using specific antibodies to endogenous LAP1 (red) and PP1γ (blue). Immunolocalization of LAP1 and PP1γ 
is observed. Z-Projections of stack images were acquired by confocal microscopy. Negative control showed no staining 
(data not shown). Sperm cells with negative staining in the nucleus with PSA-FITC (green) were considered acrosome 
reacted. 
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3.4 CONCLUSIONS 
 
As portrayed in Figure III.23, the activity of LAP1 during the mouse spermatogenic cycle is 
most evident from stage VIII until the end of spermiogenesis, which is characteristic of manchette 
development. Concomitantly, some LAP1 interactors studied in this work share a similar 
localization, namely, PP1γ2 and Lamin B1. Interestingly, γ-tubulin in human testis also seems to 
localize to the cytoplasm of elongating spermatids, which might help to understand the 
morphologic changes promoted by manchette formation. Together these proteins might support 
spermiogenesis. Through moving to the posterior pole, the chromatin binding sites at the nuclear 
envelope would possibly contribute to the achievement of the non-random, sperm specific 
chromatin distribution and cellular reshaping. Additionally, LAP1 distribution in sperm might have 
unravelled novel functional properties of this protein. Throughout the years, researchers have 
established that the NE undergoes significant changes in the course of spermiogenesis. Thereby, 
the nuclear reshaping and condensation processes seem to have a highly significant role in the 
development of healthy sperm. Hopefully, this study has contributed to the understanding of 
LAP1’s functional role during this differentiation process. 
 
Figure III.23. LAP1 and its interactors expression throughout the cycle of spermatogenesis in the mouse. This schematic 
representation illustrates the stage-specific expression of LAP1 (dark red: LAP1 localized to the NE, light red: LAP1 in the 
centriolar pole), PP1α, PP1γ, PP1γ2, Lamin B1, Lamin B1* (lamin B1 localization taken from 91,98) Lamin A/C and γ-Tubulin 
during spermatogenesis in mouse testis. There are twelve stages (designated with Roman numerals) in mouse 
spermatogenic cycle which are thoroughly depicted in the scheme.  mIn, intermediate spermatogonium prior to mitosis; 
Inm, intermediate spermatogonium after to mitosis; B, B spermatogonium; Bm, B spermatogonium undergoing mitosis; 
Pl, preleptotene spermatocyte; L, leptotene spermatocyte; Z, zygotene spermatocyte; P, pachytene spermatocyte; D, 
diplotene spermatocytes; m2om, two meiotic divisions; 1–16, 16 steps of spermatid development. Adapted from 82.
 
 
 
 
 
 
 
 
 
CONCLUDING REMARKS & FUTURE PERSPECTIVES 
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 The integrative results attained from this work allowed for the discovery of several 
prospective functions regarding the biological role of LAP1. The integration of multiple 
bioinformatic tools established novel functions to LAP1 such as DNA damage response and 
telomere association. In conjunction, bioinformatic results reinforced the association of LAP1 with 
mitosis and the already identified role of LAP1 in nuclear morphology. Furthermore, the study of 
LAP1 throughout different periods of the male reproductive system attributed potential new 
biological functions to LAP1. Thereby, this work can be the foundation of future studies regarding 
LAP1 and the regulation of multiple cellular processes and disease conditions. 
 Therefore, we propose the following complementary and future prespectives: 
 
 Investigate the functional association of LAP1 with the shelterin complex and telomeres; 
 Research the association of LAP1 with DNA damage responses, upon genotoxic insults; 
 Confirm the expression of LAP1 in the testis and sperm with immunoblotting technics; 
 Complement the present study with increasing the number of animals and patients, 
regarding IHC analysis; 
 Immunofluorescent studies to determine the colocalization profiles of LAP1 with PP1γ2, 
lamin A/C, lamin B1, γ-tubulin, α-tubulin and torsinA, in mouse and human testis, and 
sperm samples; 
 Investigate the integrity and morphology of LAP1 knockout mice testis and the distribution 
of LAP1 interactors throughout spermatogenesis; 
 Study the localization and pattern of LAP1 in sperm with comprised morphology and 
motility. 
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Cell Culture Solutions 
PBS (1x) 
For a final volume of 500 mL, dissolve one pack of BupH Modified Dulbecco’s Phosphate Buffered 
Saline Pack (Pierce) in deionised H2O. Final composition: 
 
 8 mM Sodium Phosphate 
 2 mM Potassium Phosphate 
 140 mM Sodium Chloride 
 10 mM Potassium Chloride 
Sterilize by filtering through a 0.2 μm filter and store at 4°C. 
 
 
10% FBS DMEM 
 
 13,4 g DMEM 
 3,7 g NaHCO3 
 10 mL Streptomycin/Penicillin/Amphotericin solution (AAs) 
 100 mL 10% FBS  
Dissolve in deionised H2O. Adjust the pH to 7.3. Adjust the volume to 1 L with deionised H2O. 
 
Earl’s balance solution (Sebss) 
 
 1.8 mM CaCl2 
 5.4 mM KCl 1.8 mM CaCl2 
 5.4 mM KCl, 0.81 mM MgSO4 
 25.0 mM NaHCO3 
 1.0 mM NaH2PO4, 116.4 mM NaCl 
 5.5 mM D-glucose, 2.5 mM Na–pyruvate 
 41.8 mM Na–lactate 
 0.3% BSA 
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Immunohistocheminal and Immunofluorescence Solutions 
 
4% Paraformaldehyde 
For a final volume of 100 mL, add 4 g of paraformaldehyde to 25 mL deionised H2O. Dissolve 
by heating the mixture at 58°C while stirring. Add 1-2 drops of 1 M NaOH to clarify the solution and 
filter through a 0.2 μm filter. Add 50 mL of PBS 2x and adjust the volume to 100 mL with deionised 
H2O. 
 
Bouin’s Solution 
 
 75 mL Picric acid solution 
 25 mL Formalin 
 5 mL Glacial Acetic acid 
Alternatively, combine the saturated picric acid with the formalin, and the glacial acetic 
acid. Store at 4°C. 
 
Sodium Citrate Buffer 
 
 0.1 M Citric Acid Solution (1 L): add 21.01 g of Citric Acid Monohydrate (C6H8O7.H2O) 
to deionized H2O, for a final volume of 1 L. Store at 4ᵒC. 
 
 0.1 M Sodium Citrate Solution (1 L): add 26.41 g Trisodium Citrate Dihydrate 
(C6H5Na3O7.2H2O) to deionized H2O, for a final volume of 1 L. Store at 4ᵒC. 
 
 0.1 M Sodium Citrate Buffer (500 mL), pH 6.0: add 9 mL of Citric Acid Solution (0.1M 
stock solution), and 41 mL of Sodium Citrate Solution for a final volume of 500 mL. 
Adjust the pH to 6.0 and store at 4ᵒC. 
 
Ethanol solutions (1 L) 
 
 Ethanol 96%: add 960 mL of Ethanol Absolute and 40 mL of deionized H2O. 
 Ethanol 70%: add 700 mL of Ethanol Absolute and 300 mL of deionized H2O. 
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Mayer’s Haematoxylin 
 
 25 g Aluminium potassium sulphate 
 0.5 g Haematoxylin 
 0.1 g Sodium iodate 
 10 mL Glacial Acetic Acid 
 500 mL Demi-water 
 
Dissolve aluminium potassium sulphate in demi-water. When it is completely dissolved, add 
hematoxylin. When hematoxylin is completely dissolved, add sodium iodate and acetic acid. Bring 
to boil (5 min) and cool. Filter if necessary. 
 
Blocking solutions 
 
 3% BSA: To 10 mL of PBS 1x add 0.3 g of Bovine Serum Albumine (BSA). 
 5% BSA: To 10 mL of PBS 1x add 0.5 g of BSA. 
 5% BSA + 0,01% BSA-C: To 10 mL of PBS 1x add 0.5 g of BSA and 1 μL of acetylated 
BSA. 
